Synthetic Botox molecules might help to treat Chronic Pain
Fantastic news for the Botox’ friends, this amazing molecule is not only enhancing your appearance and making you look younger and prettier, it can also reduce pain!
This month, a group of researchers from the UCL, the University of Sheffield and the Hospital for Sick Children, published a groundbreaking study showing how a derivate of Botox can provide long-lasting pain relief in mice without adverse effects.
The researchers mixed an opioid (dermorphin) with a variant of the botox molecule to create “Derm-BOT” and the molecule SP-BOT (a substance P-modified botulinum molecule). Then, they injected these molecules into the spine of different mice and found that they target and silences pain signals from neurons in the spinal cords of mice. One of the authors of the study, Dr. Steve Hunt (from UCL Cell & Developmental Biology), explained that Derm-BOT doesn't affect muscles like the botulinum toxin used to reduce wrinkles but it does block nerve pain for up to four months without affecting normal pain responses. More positive features of Derm-BOT are that it is safe to manufacture, is non-toxic and doesn’t kill neurons. The study covered 5 years and 200 mice that were treated with a single injection of Derm-BOT, SP-BOT or morphine. The behavior of the mice was monitored to track their pain-response. Both SP-BOT and Derm-BOT have a long-lasting effect in both inflammatory and neuropathic pain model, successfully silencing neurons without cell death.
Chronic pain affects more than 25 million Americans and is related to reduced life span, anxiety, and depression. Given the current opioid crisis, aka abuse, addiction and overuse of prescribed opioid painkillers, having optional treatments for chronic pain is essential. Moreover there is little evidence that opioids have along lasting effects maybe because the body builds up a tolerance to repeated drug use over the long term. Some reports indicate that opioids may increase the body's sensitivity to pain. On the other hand, a single injection of Derm-BOT reduced mechanical hypersensitivity to the same extent as morphine. More studies in mice and a follow up on humans will help to understand and progress this new treatment that brings hope to the patients suffering chronic pain.
Reference
Selective neuronal silencing using synthetic botulinum molecules alleviates chronic pain in mice
Maria Maiarù, Charlotte Leese, Michelangelo Certo, Irene Echeverria-Altuna, Antonina S. Mangione, Jason Arsenault, Bazbek Davletov and Stephen P. Hunt
Science Translational Medicine 18 Jul 2018:
Vol. 10, Issue 450, eaar7384
DOI: 10.1126/scitranslmed.aar7384
Monday, July 23, 2018
Saturday, July 7, 2018
Can Chocolate be Good for You? The Dark and Light Side of the Force
Can Chocolate be Good for You? The Dark and Light Side of the Force
By Jesica Levingston Mac leod, PhD
It is this time of the year again: World chocolate day – the best excuse to give and more importantly to EAT a lot of chocolate. But, maybe a better gift that receiving chocolate, is to know that eating chocolate might be good for your health.
In the beginning chocolate was “created” as a medicine – a healthy beverage – around 1900 BC by Mesoamerican people. The Aztecs and Mayas gave it the name of “xocolatl”, it means bitter water, as the early preparations of the cacao seeds had an intense bitter taste. Almost one year ago, a longitudinal study, done in the US East Coast, connected eating chocolate with better cognitive function. Yay! Great news, right? The scientists gathered information over a period of 30 years (starting in 1976) from 968 subjects (aged 23-98 years) in the Syracuse-Maine area. The results showed that more frequent chocolate consumption was meaningfully associated with better performance on the global composite score, visual-spatial memory and organization, working memory, scanning and tracking, abstract reasoning, and the mini-mental state examination. Importantly, they pointed out that with the exception of working memory, these relations were not attenuated with statistical control for cardiovascular, lifestyle and dietary factors across the participants.
More good news arrived last summer: an Italian research team announced that flavanol-rich chocolate improves arterial function and working memory performance counteracting the effects of sleep deprivation. The researchers investigated the effect of flavanol-rich chocolate consumption on cognitive skills and cardiovascular parameters after sleep deprivation in 32 healthy participants, who underwent two baseline sessions after one night of undisturbed sleep and two experimental sessions after one night of total sleep deprivation. Two hours before each testing session, participants were assigned to consume high or poor flavanol chocolate bars. During the tests the participants were evaluated by the psychomotor vigilance task and a working memory task, systolic blood pressure (SBP) and diastolic blood pressure (DBP), flow-mediated dilation and pulse-wave velocity. As you might know, sleep deprivation increased SBP/DBP. The result was that SBP/DBP and pulse pressure were lower after flavanol-rich treatment respect to flavanol-poor treatment sleep deprivation impaired flow-mediated dilation, flavanol-rich, but not flavanol-poor chocolate counteracted this alteration. Flavanol-rich chocolate mitigated the pulse-wave velocity increase. Also, flavanol-rich chocolate preserved working memory accuracy in women after sleep deprivation. Flow-mediated dilation correlated with working memory performance accuracy in the sleep condition.
The European Food Safety Authority accepted the following statement for cocoa products containing 200 mg of flavanols: “cocoa flavanols help maintain the elasticity of blood vessels, which contributes to normal blood flow”. This statement means that flavanol-rich chocolate counteracted vascular impairment after sleep deprivation and restored working memory performance. In another study led by Columbia University Medical Center scientists, dietary cocoa flavanols—naturally occurring bioactives found in cocoa—reversed age-related memory decline in healthy older adults. One possibility is that the improvement in cognitive performance could be due to the effects of cocoa flavonoids on blood pressure and peripheral and central blood flow. Following on this other chocolate attribute, it was shown than weekly chocolate intake may be beneficial to arterial stiffness.
But, there are some bad news! A review of 13 scientific articles on this topic, provided evidence that dark chocolate did not reduce blood pressure. However, the reviewers claimed that there was an association with increased flow-mediated vasodilatation (FMD) and moderate for an improvement in blood glucose and lipid metabolism. Specifically, their analysis showed that chocolates containing around 100 mg epicatechin can reliably increase FMD, and that cocoa flavanol doses of around 900 mg or above may decrease blood pressure if consumed over longer periods: “Out of 32 cocoa product samples analyzed, the two food supplements delivered 900 mg of total flavanols and 100 mg epicatechin in doses of 7 g and 20 g and 3 and 8 g, respectively. To achieve these doses with chocolate, you will need to consume 100 to 500 g (for 900 mg flavanols) and 50 to 200 g (for 100 mg epicatechin). Chocolate products marketed for their purported health benefits should therefore declare the amounts of total flavanols and epicatechin”. The method of manufacturing dark chocolate retains epicatechin, whereas milk chocolate does not contain substantial amounts of epicatechin.
The first epidemiological “indication” for beneficial health effects of chocolate were found in Kuna natives in Panama with low prevalence of atherosclerosis, type 2 diabetes, and hypertension. This fact correlated with their daily intake of a homemade cocoa. These traits disappear after migration to urban and changes in diet.
There are many claims about the potential health benefits of chocolate, including anti-oxidative effect by polyphenols, anti-depressant effect by high serotonin levels, inhibition of platelet aggregation and prevention of obesity-dependent insulin resistance. Chocolate contains quercetin, a powerful antioxidant that protects cells against damage from free-radicals. Chocolate also contains theobromine and caffeine, which are central nervous system stimulants, diuretics and smooth muscle relaxants, and valeric acid, which is a stress reducer. However, chocolate also contains sugar and other additives in some chocolate products that might not be so good for your health.
Oh well, maybe the love of chocolate is like any other romantic affair: blind and passionate. Apparently, the beneficial dosage is 10 g of dark chocolate per day (>70% cocoa), so enjoy it as long as the serotonin boost for rewarding yourself with a new treat last.
Happy world chocolate day!
By Jesica Levingston Mac leod, PhD
It is this time of the year again: World chocolate day – the best excuse to give and more importantly to EAT a lot of chocolate. But, maybe a better gift that receiving chocolate, is to know that eating chocolate might be good for your health.
In the beginning chocolate was “created” as a medicine – a healthy beverage – around 1900 BC by Mesoamerican people. The Aztecs and Mayas gave it the name of “xocolatl”, it means bitter water, as the early preparations of the cacao seeds had an intense bitter taste. Almost one year ago, a longitudinal study, done in the US East Coast, connected eating chocolate with better cognitive function. Yay! Great news, right? The scientists gathered information over a period of 30 years (starting in 1976) from 968 subjects (aged 23-98 years) in the Syracuse-Maine area. The results showed that more frequent chocolate consumption was meaningfully associated with better performance on the global composite score, visual-spatial memory and organization, working memory, scanning and tracking, abstract reasoning, and the mini-mental state examination. Importantly, they pointed out that with the exception of working memory, these relations were not attenuated with statistical control for cardiovascular, lifestyle and dietary factors across the participants.
More good news arrived last summer: an Italian research team announced that flavanol-rich chocolate improves arterial function and working memory performance counteracting the effects of sleep deprivation. The researchers investigated the effect of flavanol-rich chocolate consumption on cognitive skills and cardiovascular parameters after sleep deprivation in 32 healthy participants, who underwent two baseline sessions after one night of undisturbed sleep and two experimental sessions after one night of total sleep deprivation. Two hours before each testing session, participants were assigned to consume high or poor flavanol chocolate bars. During the tests the participants were evaluated by the psychomotor vigilance task and a working memory task, systolic blood pressure (SBP) and diastolic blood pressure (DBP), flow-mediated dilation and pulse-wave velocity. As you might know, sleep deprivation increased SBP/DBP. The result was that SBP/DBP and pulse pressure were lower after flavanol-rich treatment respect to flavanol-poor treatment sleep deprivation impaired flow-mediated dilation, flavanol-rich, but not flavanol-poor chocolate counteracted this alteration. Flavanol-rich chocolate mitigated the pulse-wave velocity increase. Also, flavanol-rich chocolate preserved working memory accuracy in women after sleep deprivation. Flow-mediated dilation correlated with working memory performance accuracy in the sleep condition.
The European Food Safety Authority accepted the following statement for cocoa products containing 200 mg of flavanols: “cocoa flavanols help maintain the elasticity of blood vessels, which contributes to normal blood flow”. This statement means that flavanol-rich chocolate counteracted vascular impairment after sleep deprivation and restored working memory performance. In another study led by Columbia University Medical Center scientists, dietary cocoa flavanols—naturally occurring bioactives found in cocoa—reversed age-related memory decline in healthy older adults. One possibility is that the improvement in cognitive performance could be due to the effects of cocoa flavonoids on blood pressure and peripheral and central blood flow. Following on this other chocolate attribute, it was shown than weekly chocolate intake may be beneficial to arterial stiffness.
But, there are some bad news! A review of 13 scientific articles on this topic, provided evidence that dark chocolate did not reduce blood pressure. However, the reviewers claimed that there was an association with increased flow-mediated vasodilatation (FMD) and moderate for an improvement in blood glucose and lipid metabolism. Specifically, their analysis showed that chocolates containing around 100 mg epicatechin can reliably increase FMD, and that cocoa flavanol doses of around 900 mg or above may decrease blood pressure if consumed over longer periods: “Out of 32 cocoa product samples analyzed, the two food supplements delivered 900 mg of total flavanols and 100 mg epicatechin in doses of 7 g and 20 g and 3 and 8 g, respectively. To achieve these doses with chocolate, you will need to consume 100 to 500 g (for 900 mg flavanols) and 50 to 200 g (for 100 mg epicatechin). Chocolate products marketed for their purported health benefits should therefore declare the amounts of total flavanols and epicatechin”. The method of manufacturing dark chocolate retains epicatechin, whereas milk chocolate does not contain substantial amounts of epicatechin.
The first epidemiological “indication” for beneficial health effects of chocolate were found in Kuna natives in Panama with low prevalence of atherosclerosis, type 2 diabetes, and hypertension. This fact correlated with their daily intake of a homemade cocoa. These traits disappear after migration to urban and changes in diet.
There are many claims about the potential health benefits of chocolate, including anti-oxidative effect by polyphenols, anti-depressant effect by high serotonin levels, inhibition of platelet aggregation and prevention of obesity-dependent insulin resistance. Chocolate contains quercetin, a powerful antioxidant that protects cells against damage from free-radicals. Chocolate also contains theobromine and caffeine, which are central nervous system stimulants, diuretics and smooth muscle relaxants, and valeric acid, which is a stress reducer. However, chocolate also contains sugar and other additives in some chocolate products that might not be so good for your health.
Oh well, maybe the love of chocolate is like any other romantic affair: blind and passionate. Apparently, the beneficial dosage is 10 g of dark chocolate per day (>70% cocoa), so enjoy it as long as the serotonin boost for rewarding yourself with a new treat last.
Happy world chocolate day!
Monday, April 30, 2018
Ebola – Closer than You Think
Ebola – Closer than You Think
Ebola, the hemorrhagic fever is closer than you think, but there is no reason to panic…yet!
By Jesica Levingston Mac leod, PhD
In case you did not hear about it, the Center of Disease Control (CDC) reported an outbreak of a “more virulent” Ebola virus infections in Guinea, spreading now to Sierra Leone . Ebola virus is the etiological agent of severe hemorrhagic fever. The symptoms? Fever, rash, severe abdominal pain, vomiting, and bleeding, both internally and externally. The fatality rate? Around 90%. Even worse, these outbreaks are occurring with increasing frequency. Some explanations for this are the increased contact between humans and the natural reservoir of the viruses (fruit bats), and fluctuations in viral load and prevalence in this reservoir. The transmission of the virus mostly occurs by contact with infected blood, secretions or organs of either bats, nonhuman primates or humans. This is why you should not eat bats or monkeys if you visit any of the affected areas, or hang around any cemeteries. Not surprisingly, Ebola was named as the most frightening disease in the world. It was documented for the first time in 1976 in the Republic of Congo; one of the sources came from the Ebola River.
In 2012 an outbreak in Uganda found us in a similar medical emptiness: the research of two of the vaccines that were “apparently” going great had been canceled by the department of defense, due to funding constraints. Therefore, so far we do not have any vaccine or effective treatment available.
Albeit a DNA based vaccine was described in 2003 to fully protected macaques against the fatal virus, it did not continue to further clinical trials. It was not until 10 years later that a group in the US National Institutes of Health published research about a vaccine consisting of a recombinant vesicular stomatitis virus expressing the ebola glycoprotein which protects macaques from Ebola virus infections, although this method is not licensed for human use.
But, why does the US department of defense care about an African virus? The answer is pretty obvious: it can be used as a bio hazard weapon. On the other hand, no leading pharmaceutical is going to invest in a “very expensive and time consuming” vaccine development to be used in countries that can not afford even a basic level of health care. Some compounds are showing a promising antiviral effect in vitro and/or an inhibition of a variety of viral proteins activities. Sadly, all of them are in an early stage of drug development.
Before freaking out, the best “cure” and prevention method against this scaring virus is knowledge, so check out the updates in the CDC website.
Ebola, the hemorrhagic fever is closer than you think, but there is no reason to panic…yet!
By Jesica Levingston Mac leod, PhD
In case you did not hear about it, the Center of Disease Control (CDC) reported an outbreak of a “more virulent” Ebola virus infections in Guinea, spreading now to Sierra Leone . Ebola virus is the etiological agent of severe hemorrhagic fever. The symptoms? Fever, rash, severe abdominal pain, vomiting, and bleeding, both internally and externally. The fatality rate? Around 90%. Even worse, these outbreaks are occurring with increasing frequency. Some explanations for this are the increased contact between humans and the natural reservoir of the viruses (fruit bats), and fluctuations in viral load and prevalence in this reservoir. The transmission of the virus mostly occurs by contact with infected blood, secretions or organs of either bats, nonhuman primates or humans. This is why you should not eat bats or monkeys if you visit any of the affected areas, or hang around any cemeteries. Not surprisingly, Ebola was named as the most frightening disease in the world. It was documented for the first time in 1976 in the Republic of Congo; one of the sources came from the Ebola River.
In 2012 an outbreak in Uganda found us in a similar medical emptiness: the research of two of the vaccines that were “apparently” going great had been canceled by the department of defense, due to funding constraints. Therefore, so far we do not have any vaccine or effective treatment available.
Albeit a DNA based vaccine was described in 2003 to fully protected macaques against the fatal virus, it did not continue to further clinical trials. It was not until 10 years later that a group in the US National Institutes of Health published research about a vaccine consisting of a recombinant vesicular stomatitis virus expressing the ebola glycoprotein which protects macaques from Ebola virus infections, although this method is not licensed for human use.
But, why does the US department of defense care about an African virus? The answer is pretty obvious: it can be used as a bio hazard weapon. On the other hand, no leading pharmaceutical is going to invest in a “very expensive and time consuming” vaccine development to be used in countries that can not afford even a basic level of health care. Some compounds are showing a promising antiviral effect in vitro and/or an inhibition of a variety of viral proteins activities. Sadly, all of them are in an early stage of drug development.
Before freaking out, the best “cure” and prevention method against this scaring virus is knowledge, so check out the updates in the CDC website.
Chasing the "One Drug" to Rule Them All
Chasing the "One Drug" to Rule Them All
(All meaning all the hemorrhagic fever viruses)
By Jesica Levingston Mac leod, PhD
Almost all the hemorrhagic fever viruses are listed by the World Health Organization to be only handled in Biohazard level 4 facilities, as they are potential agents of bioterrorism. These are also RNA viruses, which have a mortality ratio between 30 to 90% and there are no vaccines or effective treatment methods available. In fact, the recommended anti viral treatment; Ribavirin has not shown to be very successful in a randomized-controlled trial, as Ribavirin was not superior to no Ribavirin treatment in mortality rates. One would think that these types of viruses could only arise in far and remote regions like Argentina (in the case of Junin virus) or Congo (like the Ebola virus). However with the increase in the intercontinental travels these viruses could be closer than what you would expect.
But not all is bad news: Lu et al. examined the effect of inhibitors based on a host protein (Tsg101), and discovered an inhibitor for at least 2 negative stranded RNA viruses (Junin virus and Ebola virus). Compound 0013 could reduce Junin virus egress dissemination and disease progression in infected individuals by inhibiting the viral nucleoprotein-Tsg101 interaction. Moreover, since this Tsg101 related recruitment system is utilized by other RNA virus pathogens (e.g. Ebola virus and HIV-1), the compound 0013 has the potential to function as a broad-spectrum, host-oriented antiviral drug.
In a more advance stage of drug development, in a recent Nature article, Warren et al. showed that a compound: BCX4430, inhibits infection of Ebola and Marburg virus in human cells. Furthermore, the post exposure of this compound in rodents also protects against further viral infections. BCX4430 is a novel synthetic adenosine analogue that inhibits viral RNA polymerase function. The hallmark is that BCX4430 protects macaques from Marburg virus infection when administered as late as 48 hours after infection. Finally, BCX4430 exhibits broad-spectrum antiviral activity against other viruses, including bunyaviruses, arenaviruses, paramyxoviruses, coronaviruses and flaviviruses.
Lastly, in the Science magazine, Andrews et al. showed the efficiency of the compound GSK744 in protecting macaques against HIV infection. This drug is an integrase strand-transfer inhibitor that has been formulated as a long-acting injectable. GSK744 was administered at two time points 4 weeks apart, beginning 1 week before virus administration, and the macaques were challenged weekly for 8 weeks. GSK744, protected all animals against repeated low-dose challenges. These results suggest that GSK744 could potentially decrease adherence problems associated with daily preexposure prophylaxis and may be administered quarterly in humans. And, of course, this compound has been suggested to be use as an inhibitor for other RNA viruses.
As you can see, not all the researchers involved in drug discovery are only focus in their own virus of interest or are as avid to put the drugs in the market before passing with honors all the FDA approval test, as the movie “Dallas Buyers Club” showed us recently.
The drug discovery process is very extensive, exhausting and expensive; in order pass the reach the pre-clinical and clinical testing to pass the stringent FDA approval. Therefore, finding “the drug” than can be effective against a variety of viruses (and not toxic for humans!) could be a shortcut in medicine development.
(All meaning all the hemorrhagic fever viruses)
By Jesica Levingston Mac leod, PhD
Almost all the hemorrhagic fever viruses are listed by the World Health Organization to be only handled in Biohazard level 4 facilities, as they are potential agents of bioterrorism. These are also RNA viruses, which have a mortality ratio between 30 to 90% and there are no vaccines or effective treatment methods available. In fact, the recommended anti viral treatment; Ribavirin has not shown to be very successful in a randomized-controlled trial, as Ribavirin was not superior to no Ribavirin treatment in mortality rates. One would think that these types of viruses could only arise in far and remote regions like Argentina (in the case of Junin virus) or Congo (like the Ebola virus). However with the increase in the intercontinental travels these viruses could be closer than what you would expect.
But not all is bad news: Lu et al. examined the effect of inhibitors based on a host protein (Tsg101), and discovered an inhibitor for at least 2 negative stranded RNA viruses (Junin virus and Ebola virus). Compound 0013 could reduce Junin virus egress dissemination and disease progression in infected individuals by inhibiting the viral nucleoprotein-Tsg101 interaction. Moreover, since this Tsg101 related recruitment system is utilized by other RNA virus pathogens (e.g. Ebola virus and HIV-1), the compound 0013 has the potential to function as a broad-spectrum, host-oriented antiviral drug.
In a more advance stage of drug development, in a recent Nature article, Warren et al. showed that a compound: BCX4430, inhibits infection of Ebola and Marburg virus in human cells. Furthermore, the post exposure of this compound in rodents also protects against further viral infections. BCX4430 is a novel synthetic adenosine analogue that inhibits viral RNA polymerase function. The hallmark is that BCX4430 protects macaques from Marburg virus infection when administered as late as 48 hours after infection. Finally, BCX4430 exhibits broad-spectrum antiviral activity against other viruses, including bunyaviruses, arenaviruses, paramyxoviruses, coronaviruses and flaviviruses.
Lastly, in the Science magazine, Andrews et al. showed the efficiency of the compound GSK744 in protecting macaques against HIV infection. This drug is an integrase strand-transfer inhibitor that has been formulated as a long-acting injectable. GSK744 was administered at two time points 4 weeks apart, beginning 1 week before virus administration, and the macaques were challenged weekly for 8 weeks. GSK744, protected all animals against repeated low-dose challenges. These results suggest that GSK744 could potentially decrease adherence problems associated with daily preexposure prophylaxis and may be administered quarterly in humans. And, of course, this compound has been suggested to be use as an inhibitor for other RNA viruses.
As you can see, not all the researchers involved in drug discovery are only focus in their own virus of interest or are as avid to put the drugs in the market before passing with honors all the FDA approval test, as the movie “Dallas Buyers Club” showed us recently.
The drug discovery process is very extensive, exhausting and expensive; in order pass the reach the pre-clinical and clinical testing to pass the stringent FDA approval. Therefore, finding “the drug” than can be effective against a variety of viruses (and not toxic for humans!) could be a shortcut in medicine development.
8 Ways to Get the Best out of Networking Events
8 Ways to Get the Best out of Networking Events
By Jesica Levingston Mac leod, PhD
Para la traduccion en espanol mirar mas abajo.
When you are attending a networking event, it doesn’t matter if you are hiring, searching for a job or just increasing your LinkedIn connections, there are some simple ideas that would make you go home with a smile on your face and a lot of business cards in your pocket.
1. Know what are you looking for, as always in life
You must have your aim or goal in mind, so you can transmit it to the other people. Prepare a short introduction about yourself and your expectations in advance, and when I say short, I mean it. Nothing is more boring than a stranger giving you a dissertation on a topic that you do not care about. Therefore focus your short introductory speech according to your goal for the event. On the other hand, the “hit and run” strategy is a highway to failure. For example if you are job hunting, it is important to sell yourself to the correct people… which brings me to the next topic..
2. Connect smart!
If you start a conversation and it does not look very productive for you, do not be afraid and just say “thanks, bye” and move on, no harm done. Normally the networking events don’t last more than 2 hours and you have to take advantage of every available second.
3. Know the attendants
So try to get a list of the attendants before hand, and “Google” them in order to know if they’re important connections for you and which kind of conversations or common interest you can discuss. This is not stalking, but sometimes it is good to check out photos of people you want to talk to so you can recognize them. Moreover, leave your mark, tell then something that will make then remember you, and if you can: find a reason to keep in touch.
4. Have an ice breaker
Some tips for those shy souls: just go and say, “Hi, how are you?” and honestly wait to get an answer. You can follow it with “I am John Doe, I work in Awesome-land, what are you doing?”. Or you can ask questions such as, “do you work in….?” or “What are you drinking?” “What advice would you give to someone who wants to break into this field?” “Would you recommend with who I should speak? May I use your name as a reference?” I know it is kind of a cheesy icebreaker but it is the best shot. Everybody is there to meet people, and if you just stand around staring at the empty space the probabilities of you meeting another interesting human being are very low.
5. Dress to impress, but not too much
About the look: dress your best according with the type of event you are attending, but always let your own style show through. It’s your personality that makes you special and different, and that can be reflected in your outfit.
6. Be special
Write your name on the tag in big, clear letters (young people forget that old people can’t read small writing) and put it on the right side of your chest. Why? Because when you shake someone’s hand your right shoulder will be pointing directly at them. Also most of the people you will meet are right handed and the easier for them is to put the sticker on their left side, so you might have a possible conversation starter.
[box style=”rounded”]What about a “wing man”? Personally, I love this strategy because I team up really well with my friends, but it can be contra productive as the people can feel it overwhelming to have a crowd “attacking” them.[/box]
7. Be brave
The most important advice is to just go. Event if you are afraid of putting yourself thorough this wild networking event world, just do it. I was searching for a job when a friend convinced me to attend a biotech event at a bar. The event was not looking very successful when we had first arrived and I was regretting my decision. But, eventually a handsome man walked over to me and mentioned in a very friendly way that he was working for a company that was looking for a chemist, which I am not. I literally moonwalked far away from him as I didn’t want to waste my time. But before leaving he came back again and handed me his card, which I added to the pile. Two weeks later I updated my LinkedIn connections adding all the professionals that I met in these events and to my surprise a message came back from this handsome man inviting me for a coffee. Long story short: I met my boyfriend in a networking event. So you never know what can came out of these gatherings. One thing is sure, only positive things are born from networking. Sharing you experience, knowledge, needs and future goals with other professionals is always rewarding.
8. Let’s listen to professional advice by recruiter Nick Corcodilos
[quote style=”boxed”]True networking is when you spend time with people who do the work you want to do, talking shop. Good networking involves working with other active professionals, even if it’s on a volunteer project, or to learn something new. Good networking is rubbing elbows and enjoying talk and activities related to the work you want to do. Here’s the thing that confuses people and frustrates them: They think we network to get our next job. That’s absolutely wrong. We network to get smarter, to make new friends, to build our value and our credibility in our professional community, to help others, and to enjoy our work outside of the job. Job opportunities arise out of networking; they are not the reason to do it.[/quote]
References:
Nick Corcodilos, in Ask The Headhunter newsletter, “Too late to network?” March 18, 2008.
Where to start:
[unordered_list style=”tick”]
LinkedIN
Networking meetings in NYC – or search Eventbrite for events in your city
NetParty – networking with a twist
The NYC Business Networking group (search or start meetup for similar events near you)
By Jesica Levingston Mac leod, PhD
Para la traduccion en espanol mirar mas abajo.
When you are attending a networking event, it doesn’t matter if you are hiring, searching for a job or just increasing your LinkedIn connections, there are some simple ideas that would make you go home with a smile on your face and a lot of business cards in your pocket.
1. Know what are you looking for, as always in life
You must have your aim or goal in mind, so you can transmit it to the other people. Prepare a short introduction about yourself and your expectations in advance, and when I say short, I mean it. Nothing is more boring than a stranger giving you a dissertation on a topic that you do not care about. Therefore focus your short introductory speech according to your goal for the event. On the other hand, the “hit and run” strategy is a highway to failure. For example if you are job hunting, it is important to sell yourself to the correct people… which brings me to the next topic..
2. Connect smart!
If you start a conversation and it does not look very productive for you, do not be afraid and just say “thanks, bye” and move on, no harm done. Normally the networking events don’t last more than 2 hours and you have to take advantage of every available second.
3. Know the attendants
So try to get a list of the attendants before hand, and “Google” them in order to know if they’re important connections for you and which kind of conversations or common interest you can discuss. This is not stalking, but sometimes it is good to check out photos of people you want to talk to so you can recognize them. Moreover, leave your mark, tell then something that will make then remember you, and if you can: find a reason to keep in touch.
4. Have an ice breaker
Some tips for those shy souls: just go and say, “Hi, how are you?” and honestly wait to get an answer. You can follow it with “I am John Doe, I work in Awesome-land, what are you doing?”. Or you can ask questions such as, “do you work in….?” or “What are you drinking?” “What advice would you give to someone who wants to break into this field?” “Would you recommend with who I should speak? May I use your name as a reference?” I know it is kind of a cheesy icebreaker but it is the best shot. Everybody is there to meet people, and if you just stand around staring at the empty space the probabilities of you meeting another interesting human being are very low.
5. Dress to impress, but not too much
About the look: dress your best according with the type of event you are attending, but always let your own style show through. It’s your personality that makes you special and different, and that can be reflected in your outfit.
6. Be special
Write your name on the tag in big, clear letters (young people forget that old people can’t read small writing) and put it on the right side of your chest. Why? Because when you shake someone’s hand your right shoulder will be pointing directly at them. Also most of the people you will meet are right handed and the easier for them is to put the sticker on their left side, so you might have a possible conversation starter.
[box style=”rounded”]What about a “wing man”? Personally, I love this strategy because I team up really well with my friends, but it can be contra productive as the people can feel it overwhelming to have a crowd “attacking” them.[/box]
7. Be brave
The most important advice is to just go. Event if you are afraid of putting yourself thorough this wild networking event world, just do it. I was searching for a job when a friend convinced me to attend a biotech event at a bar. The event was not looking very successful when we had first arrived and I was regretting my decision. But, eventually a handsome man walked over to me and mentioned in a very friendly way that he was working for a company that was looking for a chemist, which I am not. I literally moonwalked far away from him as I didn’t want to waste my time. But before leaving he came back again and handed me his card, which I added to the pile. Two weeks later I updated my LinkedIn connections adding all the professionals that I met in these events and to my surprise a message came back from this handsome man inviting me for a coffee. Long story short: I met my boyfriend in a networking event. So you never know what can came out of these gatherings. One thing is sure, only positive things are born from networking. Sharing you experience, knowledge, needs and future goals with other professionals is always rewarding.
8. Let’s listen to professional advice by recruiter Nick Corcodilos
[quote style=”boxed”]True networking is when you spend time with people who do the work you want to do, talking shop. Good networking involves working with other active professionals, even if it’s on a volunteer project, or to learn something new. Good networking is rubbing elbows and enjoying talk and activities related to the work you want to do. Here’s the thing that confuses people and frustrates them: They think we network to get our next job. That’s absolutely wrong. We network to get smarter, to make new friends, to build our value and our credibility in our professional community, to help others, and to enjoy our work outside of the job. Job opportunities arise out of networking; they are not the reason to do it.[/quote]
References:
Nick Corcodilos, in Ask The Headhunter newsletter, “Too late to network?” March 18, 2008.
Where to start:
[unordered_list style=”tick”]
Networking meetings in NYC – or search Eventbrite for events in your city
NetParty – networking with a twist
The NYC Business Networking group (search or start meetup for similar events near you)
Clone wars – GMOs: Jedis or Siths?
Clone wars – GMOs: Jedis or Siths?
By Jesica Levingston Mac leod, PhD
In any molecular biology lab cloning is a daily procedure, now getting those clones outside of the lab is the huge issue. Genetic modified organisms or GMOs were subjected to specific genes alterations, and then cloned to obtain a larger number of identical organisms. Here, I would like to compare the two faces of this technology and its impact in the nature.
GMOs as Jedis, the good use of the force:
Since this technology was introduced to the field, the pesticide spraying has been reduced by 499 million kg (-8.7%) and this decreased the environmental impact associated with herbicide and insecticide use on the crops by 18.6% (as measured by the indicator the Environmental Impact Quotient [EIQ]). Furthermore, it has been reported a significant reduction in the release of greenhouse gas emissions from this cropping area, which, in 2012, was equivalent to removing 11.88 million cars from the streets.
Economically, they bring a high advantage to the farmers, allowing them to grow in a competitive environment, generating more products with a lower expenses.
GMOs are helping to supply resources to a never ending growing world population. Therefore, they could be a solution for the doomsday prediction that the economist Maltus made more than 100 years ago: “we are going to run out of resources and we won’t feed an exponential rising world population”. Science published at the beginning of 2000 a breakthrough research: the golden rice. This special GMO counts with the addition of three beta-carotene biosynthesis genes. These compounds added nutrient value to the rice, as they are precursors for the vitamin A biosyntheses. This project was leaded by Drs. Ingo Potrykus and Peter Beyer of the University of Freiburg, whom had the aim to introduce this enriched rice in the african, latin american and asian market where the deficit in this vitamin causes terrible health problems. At the time of publication, golden rice was considered a significant breakthrough in biotechnology, as the researchers had engineered an entire biosynthetic pathway. Five years later, a new version of the golden rice producing up to 23 times more beta-carotene than the original, was announced.
GMOs on the dark side of the force:
As an artificial organism that we are introducing to nature we can only try to predict how are we going to impact the environment. The ecology of this artificial selection was predicted as catastrophic, for example for the soy harvest in Argentina, where the excessive use of this GMO leaves the soil without nutrients, kind of “death” and unable to generate any other product. This exhaustion of the field may bring a negative impact in the future.
According to the center for food safety, GMOs products make up about 90 percent of cash crops like cotton, corn and soybeans nationwide. As Monsanto holds the 80% and the 90% of american corn and soybeans , respectively, and its licenses, the monopoly issue started to rise. Neither the farmers or scientist are allowed to research on the GMOs created by Monsanto, without a legal permission. This avoids the independent safety testing, and some scientists have rise the case to the US Supreme Court.
Furthermore, the farmers are subject to pay the increase price for the seeds that they can only buy for a few companies. Indeed, between 1995 and 2011, the per acre cost of corn and soybean increased 259% and 325%, respectively (US Department of Agriculture). With this strong license policy, an increasing number of small farmers have gone bankrupt as a consequence of having an accidental (like wind dispersal, split seed or cross contamination) presence of GMO on their fields. It is not surprising that with this situation the idea of changing seeds, buying a non-GMO species scares the farmers.
The labeling topic is even more sensible. The Food and Drug Administration favors voluntary labeling and says GMO products must meet the same safety levels as other foods. On the other hand the Center for Food Safety supports mandatory labeling. The GMOs producers prefer to avoid the labeling, as it brings unwanted attention to the product and bad advertising. The pro labeling organizations claim that it is the consumer right to know exactly what they are eating. My favorite comment in this regard was made by Gene Hall, a spokesman for the Texas Farm Bureau: “We don’t need to label something that is absolutely safe.”
As a great technology in development, GMOs are like Anakin Skywalker in his early age trying to decide which side of the force he should join, both present advantages and disadvantages, but without a correct guidance, like Yoda would be, this technology could be joining the dark side of the force.
By Jesica Levingston Mac leod, PhD
In any molecular biology lab cloning is a daily procedure, now getting those clones outside of the lab is the huge issue. Genetic modified organisms or GMOs were subjected to specific genes alterations, and then cloned to obtain a larger number of identical organisms. Here, I would like to compare the two faces of this technology and its impact in the nature.
GMOs as Jedis, the good use of the force:
Since this technology was introduced to the field, the pesticide spraying has been reduced by 499 million kg (-8.7%) and this decreased the environmental impact associated with herbicide and insecticide use on the crops by 18.6% (as measured by the indicator the Environmental Impact Quotient [EIQ]). Furthermore, it has been reported a significant reduction in the release of greenhouse gas emissions from this cropping area, which, in 2012, was equivalent to removing 11.88 million cars from the streets.
Economically, they bring a high advantage to the farmers, allowing them to grow in a competitive environment, generating more products with a lower expenses.
GMOs are helping to supply resources to a never ending growing world population. Therefore, they could be a solution for the doomsday prediction that the economist Maltus made more than 100 years ago: “we are going to run out of resources and we won’t feed an exponential rising world population”. Science published at the beginning of 2000 a breakthrough research: the golden rice. This special GMO counts with the addition of three beta-carotene biosynthesis genes. These compounds added nutrient value to the rice, as they are precursors for the vitamin A biosyntheses. This project was leaded by Drs. Ingo Potrykus and Peter Beyer of the University of Freiburg, whom had the aim to introduce this enriched rice in the african, latin american and asian market where the deficit in this vitamin causes terrible health problems. At the time of publication, golden rice was considered a significant breakthrough in biotechnology, as the researchers had engineered an entire biosynthetic pathway. Five years later, a new version of the golden rice producing up to 23 times more beta-carotene than the original, was announced.
GMOs on the dark side of the force:
As an artificial organism that we are introducing to nature we can only try to predict how are we going to impact the environment. The ecology of this artificial selection was predicted as catastrophic, for example for the soy harvest in Argentina, where the excessive use of this GMO leaves the soil without nutrients, kind of “death” and unable to generate any other product. This exhaustion of the field may bring a negative impact in the future.
According to the center for food safety, GMOs products make up about 90 percent of cash crops like cotton, corn and soybeans nationwide. As Monsanto holds the 80% and the 90% of american corn and soybeans , respectively, and its licenses, the monopoly issue started to rise. Neither the farmers or scientist are allowed to research on the GMOs created by Monsanto, without a legal permission. This avoids the independent safety testing, and some scientists have rise the case to the US Supreme Court.
Furthermore, the farmers are subject to pay the increase price for the seeds that they can only buy for a few companies. Indeed, between 1995 and 2011, the per acre cost of corn and soybean increased 259% and 325%, respectively (US Department of Agriculture). With this strong license policy, an increasing number of small farmers have gone bankrupt as a consequence of having an accidental (like wind dispersal, split seed or cross contamination) presence of GMO on their fields. It is not surprising that with this situation the idea of changing seeds, buying a non-GMO species scares the farmers.
The labeling topic is even more sensible. The Food and Drug Administration favors voluntary labeling and says GMO products must meet the same safety levels as other foods. On the other hand the Center for Food Safety supports mandatory labeling. The GMOs producers prefer to avoid the labeling, as it brings unwanted attention to the product and bad advertising. The pro labeling organizations claim that it is the consumer right to know exactly what they are eating. My favorite comment in this regard was made by Gene Hall, a spokesman for the Texas Farm Bureau: “We don’t need to label something that is absolutely safe.”
As a great technology in development, GMOs are like Anakin Skywalker in his early age trying to decide which side of the force he should join, both present advantages and disadvantages, but without a correct guidance, like Yoda would be, this technology could be joining the dark side of the force.
Fasting Can Make You Healthier
By Jesica Levingston Mac leod, PhD
Believe it or not, breakthrough new research has shown that fasting could be good for you. The article was indeed featured in the Nature journal and the impact of this study relies on the conclusion that fasting promotes haematopoietic stem cell (HSC) function. Stem cells are good for you because they can differentiate into specialized cells and can divide to produce more stem cells.
I personally challenged myself by fasting during Ramadan. Ramadan is one of the pillars of the Muslim religion. It consists of fasting during a month from sunrise to sunset in order to reflect the essence of piety and to be aware of the plight of the underprivileged. Other cultures include fasting in their practices. In the Jewish religion, the fasting day is named Yom Kippur, the Day of Atonement. It is described as a Jewish festival without food, but full of praying, introspection and self-judgment.
During my fasting period, my friends noticed an off-character onset of passive-aggressiveness in me, and indeed I was pretty cranky… and super hungry. One of my favorite comedians, Luis CK, once said that we incorrectly overuse the “I am starving” phrase, while people in Africa are really dying from starvation… so I won’t say I was starving, but certainly, I was in a glucose deprived state of mind, which was affecting my behavior.
The most challenging part for me was being dehydrated, as you should also fast liquids during Ramadan, fasting liquids seemed counterproductive in my experience.
Fasting is often indicated in general medical practice particularly prior to surgery or other procedures that require general anesthetics, because of the risk of pulmonary aspiration of gastric contents after induction of anesthesia (i.e., vomiting and inhaling the vomit, causing life-threatening aspiration pneumonia). One should also fast if undergoing a cholesterol or glucose test, as these measurements require a 12 hour fasting period so that a baseline can be established. These acute/short fasting periods are generally safe.
Furthermore, a study in mice published in 2008 showed that short-term fasting (less than 48 hours) is effective in protecting normal cells but not cancer cells against high dose chemotherapy. The following year another study published in Science proved that caloric restriction delays disease onset and mortality in rhesus monkeys. In a human study, including 10 cancer patients under chemotherapy, Sadfie and collaborators did not report significant side effects caused by fasting alone other than hunger and lightheadedness. In this study, all patients voluntarily fasted for a total of 48 to 140 hours prior to and/or 5 to 56 hours following chemotherapy administered by their treating oncologists. In those patients whose cancer progression could be assessed, fasting did not prevent the chemotherapy-induced reduction of tumor volume or tumor markers. Fasting was well-tolerated and was associated with a self-reported reduction in multiple chemotherapy-induced side effects, suggesting that fasting in combination with chemotherapy is feasible, safe, and has the potential to ameliorate side effects caused by chemotherapies.
In the significant article that I mentioned before, Chen and collaborators showed that prolonged fasting (PF), exceeding 48 hours, activates a metabolic switch to lipid- and ketone-based catabolism and decreases circulating insulin-like growth factor-1 (IGF-1), which has been shown to reduce chemotoxicity (1) How? They couldn’t find an answer yet. However, they clearly demonstrated that the decrease of circulating IGF-1 in the blood was accompanied by a reduction in protein kinase A (PKA) pathway activity in a variety of cell types. PKA has several functions in the cell, I.e. regulation of glycogen, sugar, and lipid metabolism and it regulates other proteins with a valuable role in stem cell stress resistance, self-renewal and pluripotency maintenance.
Interestingly, when Chen and collaborators exposed mice to cycles of prolonged fasting followed by challenges with cyclophosphamide (a drug used in chemotherapy), they noticed a reduction in the mortality and apoptosis (programmed cell death) of long- and short-term HSCs as well as multipotent progenitors in the bone marrow. In addition, multi-lineage differentiation was improved in these animals compared with fed mice, in vitro and in transplantation experiments. These positive effects of prolonged fasting were independent of the chemotherapy treatment, as they were also present in aged animals, which naturally exhibit a reduction in HSC function and multi-lineage potential. The effects of prolonged fasting could be reproduced in mice lacking the growth hormone receptor, which also have low levels of IGF-1. Transplantation experiments showed that low levels of IFG-1 in animals led to a reduction in IGF-1-mediated PKA signaling, both in haematopoietic cells and in associated stromal cells. Strikingly, the researchers could restore haematopoietic function by reducing the levels of either IGF-R1 or the PKA catalytic subunit. Conversely, the benefits were abolished if exogenous IGF-1 was added.
The scientific community is excited about these findings, and we hope understanding the positive effects of fasting can have implications in improving the quality of life of cancer patients… and all humanity in general. On the other hand, I must cite one of the best Americans: “He that lives upon hope will die fasting”, Benjamin Franklin.
Predicting Suicide
Predicting Suicide
By Jesica Levingston Mac leod, PhD
The play “suicide is forbidden in spring”. written by Alejandro Casona, describes an organization that helps potential suicide patients to end their lives, but the truth is that the doctors really want to avoid the sad end, and… they actually save the patients. They work with the “leitmotiv” that if you really want to finish your life, you will just do it, but the search for help is an indicator or alert signal of some survival and seek for attention behavior.
As reported by the Health Research found worldwide, 1 million suicides are committed by year. This means 1 death every 40 seconds. According to the CDC, In United States the percentage of suicidal is around 0.012%, where is the 10th leading cause of death. North America has 1 suicide every 13 minutes.The suicidal capital of the world is Greenland with a 108.1 suicide rate, followed by South Korea with 31.7. China is in the seventh place, it accounts for almost one third of all the suicides, and differently than the other countries it is the only one where women have a higher suicidal rate than men. Indeed, 3 years ago the terrible news about how in some factories, like Foxconn, making sought-after Apple iPads and iPhones were forcing staff to sign pledges not to commit suicide. Among 2013 at least 14 workers at Foxconn factories have taken the decision of terminating the horrendous working and housing conditions, ending their lives.
This initiative to attempt against your own life was been related to mental illness (almost in 50% of the cases) and metabolic disorders. The most implemented way of killing themselves is firearms, followed by suffocation/hanging and falls. The alarming fact is that rates of suicide have increased by 60% in the last 30 years, especially in developed countries. Also, you must consider that for every suicide that results in death there are between 10 to 40 attempted suicides. But what does bring a human been to the edge… and push him to jump?
New research has found that the answer would be the lack of the correct expression of one gene. Yes, only the downregulation of SKA2, the guilty gene, could be a biomarker for detecting suicidal behaviors. SKA2 stands for spindle and kinetochore associated complex subunit 2. The protein encoded by this gene is part of a microtubule biding complex that is essential for proper chromosomal segregation.
When they examined the postmortem brain samples from 3 independent cohorts (around 29 from suicide assesd humans and 29 controls per each group) they found that SKA2 had lower expression levels in the suicide cases than in the control, and its expression was negatively associated with DNA methylation. The chemical addition of a methyl group can activate or negatively modulate a gene, as it is considered an epigenetic modification.
I guess you are thinking: these are “Frankenstein” samples, how can this gene be related to really live human beings? Well, apparently the Johns Hopkins researchers also made the same question. In order to answer it they collected blood samples from other 3 independent cohorts with suicidal ideation and controls (with a number of subjects of 22, 51 and 327 each). In these study, the expression of the SKA2 gene was significantly reduced in suicide decedents. Furthermore, they analyzed levels of salivary cortisol. Cortisol is implicated in the glucocorticoid receptor transactivation and stress response. The results suggested that SKA2 epigenetic and genetic variation may modulate cortisol expression. The most important discovery was that the model that they generated based on these data allowed them to predict the suicidal ideation of subjects just using blood samples. They analyzed the methylated status of the SKA2 gene, which correlated with the suicidal attempts.
The great thinker Albert Camus ones recalled the attention in this issue when he said: “There is but one truly serious philosophical problem and that is suicide.” For some in risk groups, like the soldiers who are coming back home with traumas after the war, the possibility of attempts against their lives is a ghost that has taken a lot of lives. This simple blood test can point out which individuals could be in risk and therefore they may get a correct follow up and treatment that might end preventing the catastrophe. Some high pressure jobs can also implement this analysis to avoid the lost of lives, giving correct care to people who tested positive. And even closer to all: would you like to know if you have this tendency printed on your DNA? Or your partner? Or your kids?
While you think about this, let me leave you with a relief quote: “If I had no sense of humor, I would long ago have committed suicide.” Perhaps, you would be surprise to know that the wise man who said this was the Dr. Mahatma Gandhi, whom almost killed himself in a starving protest trying to obtain the independence of the Indian Republic.
By Jesica Levingston Mac leod, PhD
The play “suicide is forbidden in spring”. written by Alejandro Casona, describes an organization that helps potential suicide patients to end their lives, but the truth is that the doctors really want to avoid the sad end, and… they actually save the patients. They work with the “leitmotiv” that if you really want to finish your life, you will just do it, but the search for help is an indicator or alert signal of some survival and seek for attention behavior.
As reported by the Health Research found worldwide, 1 million suicides are committed by year. This means 1 death every 40 seconds. According to the CDC, In United States the percentage of suicidal is around 0.012%, where is the 10th leading cause of death. North America has 1 suicide every 13 minutes.The suicidal capital of the world is Greenland with a 108.1 suicide rate, followed by South Korea with 31.7. China is in the seventh place, it accounts for almost one third of all the suicides, and differently than the other countries it is the only one where women have a higher suicidal rate than men. Indeed, 3 years ago the terrible news about how in some factories, like Foxconn, making sought-after Apple iPads and iPhones were forcing staff to sign pledges not to commit suicide. Among 2013 at least 14 workers at Foxconn factories have taken the decision of terminating the horrendous working and housing conditions, ending their lives.
This initiative to attempt against your own life was been related to mental illness (almost in 50% of the cases) and metabolic disorders. The most implemented way of killing themselves is firearms, followed by suffocation/hanging and falls. The alarming fact is that rates of suicide have increased by 60% in the last 30 years, especially in developed countries. Also, you must consider that for every suicide that results in death there are between 10 to 40 attempted suicides. But what does bring a human been to the edge… and push him to jump?
New research has found that the answer would be the lack of the correct expression of one gene. Yes, only the downregulation of SKA2, the guilty gene, could be a biomarker for detecting suicidal behaviors. SKA2 stands for spindle and kinetochore associated complex subunit 2. The protein encoded by this gene is part of a microtubule biding complex that is essential for proper chromosomal segregation.
When they examined the postmortem brain samples from 3 independent cohorts (around 29 from suicide assesd humans and 29 controls per each group) they found that SKA2 had lower expression levels in the suicide cases than in the control, and its expression was negatively associated with DNA methylation. The chemical addition of a methyl group can activate or negatively modulate a gene, as it is considered an epigenetic modification.
I guess you are thinking: these are “Frankenstein” samples, how can this gene be related to really live human beings? Well, apparently the Johns Hopkins researchers also made the same question. In order to answer it they collected blood samples from other 3 independent cohorts with suicidal ideation and controls (with a number of subjects of 22, 51 and 327 each). In these study, the expression of the SKA2 gene was significantly reduced in suicide decedents. Furthermore, they analyzed levels of salivary cortisol. Cortisol is implicated in the glucocorticoid receptor transactivation and stress response. The results suggested that SKA2 epigenetic and genetic variation may modulate cortisol expression. The most important discovery was that the model that they generated based on these data allowed them to predict the suicidal ideation of subjects just using blood samples. They analyzed the methylated status of the SKA2 gene, which correlated with the suicidal attempts.
The great thinker Albert Camus ones recalled the attention in this issue when he said: “There is but one truly serious philosophical problem and that is suicide.” For some in risk groups, like the soldiers who are coming back home with traumas after the war, the possibility of attempts against their lives is a ghost that has taken a lot of lives. This simple blood test can point out which individuals could be in risk and therefore they may get a correct follow up and treatment that might end preventing the catastrophe. Some high pressure jobs can also implement this analysis to avoid the lost of lives, giving correct care to people who tested positive. And even closer to all: would you like to know if you have this tendency printed on your DNA? Or your partner? Or your kids?
While you think about this, let me leave you with a relief quote: “If I had no sense of humor, I would long ago have committed suicide.” Perhaps, you would be surprise to know that the wise man who said this was the Dr. Mahatma Gandhi, whom almost killed himself in a starving protest trying to obtain the independence of the Indian Republic.
Why Panic Can Accelerate the Therapies Discovery
Why Panic Can Accelerate the Therapies Discovery
Jesica Levingston Mac leod, PhD
In March, the Center of Disease Control (CDC) reported an outbreak of a “more virulent” Ebola virus infection in Guinea and Sierra Leone .Now, the disease has been spread to Liberia and Nigeria, among other West Africa countries. The final count is more than 1600 confirmed cases of Ebola hemorrhagic fever, with almost 900 deaths caused for this syndrome. Some of these cases included health-care workers. Indeed, two medical doctors were taken back to US to be treated with a new cocktail in the Emory University Hospital facilities in Atlanta, GA. Some Americans began to panic, for example Jon Stewart said in his show that “They are importing Ebola”.
Last week, two patients with Ebola like symptoms were all over the news. One of these cases happened in the New York City Mount Sinai Hospital, and the patient was isolated and tested right away. The hospital sent an email to all the employees updating them about the situation, and the press took over it. The bright side of the situation, in addition to the negative test result for Ebola virus, was the fast reply. The dark side was the paranoia and the lack of information and knowledge about this virus from the Manhattan community. It was alarming to read that some neighbors did not want to go to the emergency room in the hospital for fear to get infected. Well, you can’t get infected just for seating next to a sick person, or talk, or shake your hands: it is not an airborne transmitted virus.
The other problem is that the symptoms are pretty similar to other more “common” diseases: Fever, rash, severe abdominal pain, vomiting, and bleeding, both internally and externally. The difference is that the fatality rate is more than 60%. The transmission of the virus mostly occurs by contact with infected blood, secretions or organs of either bats, nonhuman primates or humans. This is why you should not eat bats or monkeys if you visit any of the affected areas, or hang around any cemeteries. Not surprisingly, Ebola was named as the most frightening disease in the world. It was documented for the first time in 1976 in the Republic of Congo; one of the sources came from the Ebola River.
In 2012 an outbreak in Uganda found us in a similar medical emptiness: the research of two of the vaccines that were “apparently” going great had been canceled by the department of defense, due to funding constraints. Therefore, so far we do not have any vaccine or effective treatment available.
In 2009, Dr. Feldmann, by then working in Canada (now in Montana, US), developed a vaccine that was used years after in Germany when a researcher accidentally pricked her finger with a syringe containing Ebola The Feldmann’s vaccine consists in a recombinant vesicular stomatitis virus expressing the Ebola glycoprotein which protects macaques from Ebola virus infections; although this method is not licensed for human use and the government founding has been random. A similar vaccine has been produce by Profectus BioSciences in Tarrytown, New York, but they are also short in the monetary founding that will push the research to the human trials.
The famous ZMapp serum, the treatment that the 2 Americans are receiving, is a cocktail of humanized, three-monoclonal- antibodies. This “cure” was the result of the collaboration of 25 laboratories among seven countries. The project, funded by the National Institute of Allergy and Infectious Diseases (NIAID), has a total budget of $28 millions. The scientific leader is the Dr. Erica Ollmann-Shapire, whom claimed that she would take the cocktail without doubts if she would be infected. Also the company Mapp Biopharmaceutical, based in California, is the principal producer of these antibodies. The initial trials in macaques were very successful, but the approval for the use in human trial is pending until 2015.
A lot of laboratories along the world are working towards the better understanding of the Ebola virus and the possible vaccines and cures. Most of these researches are founded by the US Department of Defense. But, why does the US Department of Defense care about an African virus? The answer is pretty obvious: it can be used as a bio hazard weapon. On the other hand, no leading pharmaceutical is going to invest in a “very expensive and time consuming” vaccine development to be used in countries that can’t afford even a basic level of health care. Some compounds are showing a promising antiviral effect in vitro and/or an inhibition of a variety of viral proteins activities. Sadly, all of them are in an early stage of drug development. On the other hand,the actual need for a therapy and a vaccine to stop this outbreak is speeding the drug development process.
Before freaking out, the best prevention method against this scaring virus is knowledge, so check out the updates in the CDC website.
Jesica Levingston Mac leod, PhD
In March, the Center of Disease Control (CDC) reported an outbreak of a “more virulent” Ebola virus infection in Guinea and Sierra Leone .Now, the disease has been spread to Liberia and Nigeria, among other West Africa countries. The final count is more than 1600 confirmed cases of Ebola hemorrhagic fever, with almost 900 deaths caused for this syndrome. Some of these cases included health-care workers. Indeed, two medical doctors were taken back to US to be treated with a new cocktail in the Emory University Hospital facilities in Atlanta, GA. Some Americans began to panic, for example Jon Stewart said in his show that “They are importing Ebola”.
Last week, two patients with Ebola like symptoms were all over the news. One of these cases happened in the New York City Mount Sinai Hospital, and the patient was isolated and tested right away. The hospital sent an email to all the employees updating them about the situation, and the press took over it. The bright side of the situation, in addition to the negative test result for Ebola virus, was the fast reply. The dark side was the paranoia and the lack of information and knowledge about this virus from the Manhattan community. It was alarming to read that some neighbors did not want to go to the emergency room in the hospital for fear to get infected. Well, you can’t get infected just for seating next to a sick person, or talk, or shake your hands: it is not an airborne transmitted virus.
The other problem is that the symptoms are pretty similar to other more “common” diseases: Fever, rash, severe abdominal pain, vomiting, and bleeding, both internally and externally. The difference is that the fatality rate is more than 60%. The transmission of the virus mostly occurs by contact with infected blood, secretions or organs of either bats, nonhuman primates or humans. This is why you should not eat bats or monkeys if you visit any of the affected areas, or hang around any cemeteries. Not surprisingly, Ebola was named as the most frightening disease in the world. It was documented for the first time in 1976 in the Republic of Congo; one of the sources came from the Ebola River.
In 2012 an outbreak in Uganda found us in a similar medical emptiness: the research of two of the vaccines that were “apparently” going great had been canceled by the department of defense, due to funding constraints. Therefore, so far we do not have any vaccine or effective treatment available.
In 2009, Dr. Feldmann, by then working in Canada (now in Montana, US), developed a vaccine that was used years after in Germany when a researcher accidentally pricked her finger with a syringe containing Ebola The Feldmann’s vaccine consists in a recombinant vesicular stomatitis virus expressing the Ebola glycoprotein which protects macaques from Ebola virus infections; although this method is not licensed for human use and the government founding has been random. A similar vaccine has been produce by Profectus BioSciences in Tarrytown, New York, but they are also short in the monetary founding that will push the research to the human trials.
The famous ZMapp serum, the treatment that the 2 Americans are receiving, is a cocktail of humanized, three-monoclonal- antibodies. This “cure” was the result of the collaboration of 25 laboratories among seven countries. The project, funded by the National Institute of Allergy and Infectious Diseases (NIAID), has a total budget of $28 millions. The scientific leader is the Dr. Erica Ollmann-Shapire, whom claimed that she would take the cocktail without doubts if she would be infected. Also the company Mapp Biopharmaceutical, based in California, is the principal producer of these antibodies. The initial trials in macaques were very successful, but the approval for the use in human trial is pending until 2015.
A lot of laboratories along the world are working towards the better understanding of the Ebola virus and the possible vaccines and cures. Most of these researches are founded by the US Department of Defense. But, why does the US Department of Defense care about an African virus? The answer is pretty obvious: it can be used as a bio hazard weapon. On the other hand, no leading pharmaceutical is going to invest in a “very expensive and time consuming” vaccine development to be used in countries that can’t afford even a basic level of health care. Some compounds are showing a promising antiviral effect in vitro and/or an inhibition of a variety of viral proteins activities. Sadly, all of them are in an early stage of drug development. On the other hand,the actual need for a therapy and a vaccine to stop this outbreak is speeding the drug development process.
Before freaking out, the best prevention method against this scaring virus is knowledge, so check out the updates in the CDC website.
Squeezed Science – Should We Switch to a Business Mindset?
Squeezed Science – Should We Switch to a Business Mindset?
By Jesica Levingston Mac leod, PhD
It is a common conversation topic among researchers, but it was not until the NPR article saw the light, and the dark side, that the public realized the problems that young scientists are facing when pursuing a successful career in Academia. As we raise awareness about these tribulations, my colleagues mentioned how a “postdoc”’s quality life depends on the quality of the lab, the institution, the project, the relationships with colleagues and the Principal investigator or PI (the boss), not forgetting that this is a very self driven career. So, if your hypothesis is very difficult to prove, or you have been hitting your head against the wall with all the negative results that took you years to get, you may eventually come to hating this path and leaving Academia. The same if you have been working in a non “hot field” where the funding sources do not consider interesting enough to support or your PI is not supportive, or you have a very wicked competence inside or outside the lab. All these negative situations can aggravate the perspective of the very little options one may have by pursuing a career in Academia. On the other hand, if you are obtaining excellent results, publishing in top tier journals, made hundreds of good connections and collaborators, have a “great boss” and literally love you job… well, probably you are also doomed…
One solution could be implementing the business approach to the scientific mindset: Why only having one PI per lab? At the end, two minds think more than 1. Perhaps collaborative research centers have a solution were 2 or more PIs can have access to more equipment, grants and professionals, and therefore use the best skills needed for the job, like a company where you have an executive committee and you distribute the stock between the employees, in order to make them be part of the enterprise.
Having a business mindset would mean to have a planed strategy about your career development. Having a backup career plan is one example of this: starting to apply for jobs before needed, or before it is too late. Begin with your preparation to be a leader, and make your PI know, and discuss a good starting point. Look for leadership opportunities in any situations, such as coordinating workshops or conferences.
Sign up to run workshops and career developing series!. Many postdocs can discover a great professional gain if these opportunities would be offer to them. Get training in other expertise to be competitive in, for example, the investing or consulting field. Taking classes about how to give a class is a great example of a course that could be offered to postdocs and graduate students, in order to train them to explain and transfer their empirical knowledge to the next generation.
A month ago, at the Mount Sinai Postdoc symposium, Dr. Bruce Alberts (yes, THE Alberts, from “The Molecular Biology of the Cell” book) who spoke about “The Future of Biology: Keeping Science Healthy” and illustrated the dramatic changes in the age of the scientist successfully obtaining project grants from NIH. In contrast to 30 years ago, the average age of new investigators with PhD at initial RO1 was 36.8 year old, a large number of grants were awarded to scientist in their early 30s, but this tendency has been decreasing drastically, to the point where now, the mean age for receiving these prestigious grants is 42 years of age. Dr. Alberts, himself, made fun on the fact that he obtained his postdoc position, before been awarded with his PhD. (which actually his thesis was rejected the first time, delaying the whole process) and learned from his failures. He also pointed out that he got his professor position at a very young age, something that is almost impossible nowadays. He advocated for a change in this unfair situation, which cripples the young innovators from getting a start. Also, he encouraged researchers to get out of the lab and talk to the public about science and its importance. First, to attract/engage curious minds to the scientific field, and second to communicate “in simple language” what we do for 9 hours plus per day in the lab.
We must offer to all this new scientific minds the reality about the current situation of science, but we also need to fix it, so it is not going to turn into a snow ball and make disappear all the interest in pursuing a scientific career for the new generations. In a business mind-set we must recognize that the money is not only in the governmental funding, but also in private foundations and other organizations like angels or venture capitals. So go out there and try to pitch your science to investors.
By Jesica Levingston Mac leod, PhD
It is a common conversation topic among researchers, but it was not until the NPR article saw the light, and the dark side, that the public realized the problems that young scientists are facing when pursuing a successful career in Academia. As we raise awareness about these tribulations, my colleagues mentioned how a “postdoc”’s quality life depends on the quality of the lab, the institution, the project, the relationships with colleagues and the Principal investigator or PI (the boss), not forgetting that this is a very self driven career. So, if your hypothesis is very difficult to prove, or you have been hitting your head against the wall with all the negative results that took you years to get, you may eventually come to hating this path and leaving Academia. The same if you have been working in a non “hot field” where the funding sources do not consider interesting enough to support or your PI is not supportive, or you have a very wicked competence inside or outside the lab. All these negative situations can aggravate the perspective of the very little options one may have by pursuing a career in Academia. On the other hand, if you are obtaining excellent results, publishing in top tier journals, made hundreds of good connections and collaborators, have a “great boss” and literally love you job… well, probably you are also doomed…
One solution could be implementing the business approach to the scientific mindset: Why only having one PI per lab? At the end, two minds think more than 1. Perhaps collaborative research centers have a solution were 2 or more PIs can have access to more equipment, grants and professionals, and therefore use the best skills needed for the job, like a company where you have an executive committee and you distribute the stock between the employees, in order to make them be part of the enterprise.
Having a business mindset would mean to have a planed strategy about your career development. Having a backup career plan is one example of this: starting to apply for jobs before needed, or before it is too late. Begin with your preparation to be a leader, and make your PI know, and discuss a good starting point. Look for leadership opportunities in any situations, such as coordinating workshops or conferences.
Sign up to run workshops and career developing series!. Many postdocs can discover a great professional gain if these opportunities would be offer to them. Get training in other expertise to be competitive in, for example, the investing or consulting field. Taking classes about how to give a class is a great example of a course that could be offered to postdocs and graduate students, in order to train them to explain and transfer their empirical knowledge to the next generation.
A month ago, at the Mount Sinai Postdoc symposium, Dr. Bruce Alberts (yes, THE Alberts, from “The Molecular Biology of the Cell” book) who spoke about “The Future of Biology: Keeping Science Healthy” and illustrated the dramatic changes in the age of the scientist successfully obtaining project grants from NIH. In contrast to 30 years ago, the average age of new investigators with PhD at initial RO1 was 36.8 year old, a large number of grants were awarded to scientist in their early 30s, but this tendency has been decreasing drastically, to the point where now, the mean age for receiving these prestigious grants is 42 years of age. Dr. Alberts, himself, made fun on the fact that he obtained his postdoc position, before been awarded with his PhD. (which actually his thesis was rejected the first time, delaying the whole process) and learned from his failures. He also pointed out that he got his professor position at a very young age, something that is almost impossible nowadays. He advocated for a change in this unfair situation, which cripples the young innovators from getting a start. Also, he encouraged researchers to get out of the lab and talk to the public about science and its importance. First, to attract/engage curious minds to the scientific field, and second to communicate “in simple language” what we do for 9 hours plus per day in the lab.
We must offer to all this new scientific minds the reality about the current situation of science, but we also need to fix it, so it is not going to turn into a snow ball and make disappear all the interest in pursuing a scientific career for the new generations. In a business mind-set we must recognize that the money is not only in the governmental funding, but also in private foundations and other organizations like angels or venture capitals. So go out there and try to pitch your science to investors.
If Only Santa Would be Real…When Are We Going to Have a Universal Flu Vaccine?
If Only Santa Would be Real…When Are We Going to Have a Universal Flu Vaccine?
By Jesica Levingston Mac leod, PhD
Wouldn’t it be great if the answer to that question was “next year” (yep, only a 1 month wait). Sadly, besides all the astonishing efforts of various researchers groups we are just entering the clinical studies that might lead towards a safe and effective vaccine.
Probably you already heard about the antigenic mismatch with the current vaccine (for the strain H3N2): this means that the strains used in the vaccine could potentially not completely cover one or more of the seasonal influenza virus varieties. Therefore, if you got the flu shot, you might get sick anyways.
The concept behind the universal vaccine is to bypass the antigenic mismatch problem and other issues related with the way in which the vaccines are formulated nowadays. As Drs. Natali Pica and Peter Palese explained last year (Pica et al. 2013), the vaccines are prepared year by year with the aim to protect against the virus strains that are predicted to circulate in the next period. But, and there is always a “but” in predictions, an unexpected mutation in the virus not contemplated in the vaccine production, could conclude in a pandemic.
The clue came from thinking outside of the box, and breaking with the traditional dogmas in flu vaccine production. When you get infected with the influenza virus, your immune system targets the head domain of the HA (Hemagglutinin) protein, so the current vaccine production approach was to aim for this antigen. The bad news is that this domain changes every year. The flu vaccines are based on inactivated viruses , when you receive this vaccine, you will generate antibodies to fight these specific HA proteins. In Dr. Palese’s lab they are focus on regions of influenza HA protein that are highly conserved across virus subtypes, like the stalk domain of the HA protein. Also, he is engineering different HA chimeras. This strategy has been really successful, showing protection in animal models (mice and ferrets), and the vaccines were approved to go to clinical trial next year. This universal vaccine offered good protection for pandemics H5N1 and H7N9 influenza viruses.
Another strategy, published in Nature Medicine (Sridhar et al.) reports that targeting conserved core proteins using virus-specific CD8+ T cells (lymphocytes or white blood cells with a vital role in the immune system) could provide a draft for a universal influenza vaccine. But… even the scientists implicated in the research were not very positive about how long is going to take to translate this technique to the “outside the lab” world.
The third strategy is coming from an Italian group (Vitelli et al. 2013), and this potential universal influenza vaccine is been tested in animal models by the FDA. This vaccine uses as a vector the virus PanAd3 (it was isolated from a great ape), which carries 2 genes that express proteins conserved among a variety of influenza viruses. The 2 viral proteins, the matrix protein (M1) and the nucleoprotein (NP), could be expressed for the human cells infected with the recombinant PanAd3 virus and immunize the patient against different influenza viruses.
Other entrepreneurial ideas are blooming around the world in order to solver the “influenza virus infection” problem. The influenza virus kills around 500,000 people annually worldwide (WHO), and affects very negatively the life of other hundreds of thousands. In fact, I do not know anybody who did not got the flu at least ones, I encourage to try to find somebody who was never sick with flu symptoms. This points out how universal this problem is and therefore it should get an universal solution soon.
By Jesica Levingston Mac leod, PhD
Wouldn’t it be great if the answer to that question was “next year” (yep, only a 1 month wait). Sadly, besides all the astonishing efforts of various researchers groups we are just entering the clinical studies that might lead towards a safe and effective vaccine.
Probably you already heard about the antigenic mismatch with the current vaccine (for the strain H3N2): this means that the strains used in the vaccine could potentially not completely cover one or more of the seasonal influenza virus varieties. Therefore, if you got the flu shot, you might get sick anyways.
The concept behind the universal vaccine is to bypass the antigenic mismatch problem and other issues related with the way in which the vaccines are formulated nowadays. As Drs. Natali Pica and Peter Palese explained last year (Pica et al. 2013), the vaccines are prepared year by year with the aim to protect against the virus strains that are predicted to circulate in the next period. But, and there is always a “but” in predictions, an unexpected mutation in the virus not contemplated in the vaccine production, could conclude in a pandemic.
The clue came from thinking outside of the box, and breaking with the traditional dogmas in flu vaccine production. When you get infected with the influenza virus, your immune system targets the head domain of the HA (Hemagglutinin) protein, so the current vaccine production approach was to aim for this antigen. The bad news is that this domain changes every year. The flu vaccines are based on inactivated viruses , when you receive this vaccine, you will generate antibodies to fight these specific HA proteins. In Dr. Palese’s lab they are focus on regions of influenza HA protein that are highly conserved across virus subtypes, like the stalk domain of the HA protein. Also, he is engineering different HA chimeras. This strategy has been really successful, showing protection in animal models (mice and ferrets), and the vaccines were approved to go to clinical trial next year. This universal vaccine offered good protection for pandemics H5N1 and H7N9 influenza viruses.
Another strategy, published in Nature Medicine (Sridhar et al.) reports that targeting conserved core proteins using virus-specific CD8+ T cells (lymphocytes or white blood cells with a vital role in the immune system) could provide a draft for a universal influenza vaccine. But… even the scientists implicated in the research were not very positive about how long is going to take to translate this technique to the “outside the lab” world.
The third strategy is coming from an Italian group (Vitelli et al. 2013), and this potential universal influenza vaccine is been tested in animal models by the FDA. This vaccine uses as a vector the virus PanAd3 (it was isolated from a great ape), which carries 2 genes that express proteins conserved among a variety of influenza viruses. The 2 viral proteins, the matrix protein (M1) and the nucleoprotein (NP), could be expressed for the human cells infected with the recombinant PanAd3 virus and immunize the patient against different influenza viruses.
Other entrepreneurial ideas are blooming around the world in order to solver the “influenza virus infection” problem. The influenza virus kills around 500,000 people annually worldwide (WHO), and affects very negatively the life of other hundreds of thousands. In fact, I do not know anybody who did not got the flu at least ones, I encourage to try to find somebody who was never sick with flu symptoms. This points out how universal this problem is and therefore it should get an universal solution soon.
You Can Help Cure Ebola!
You Can Help Cure Ebola!
By Jesica Levingston Mac leod, PhD
Since the start of the outbreak last March, Ebola virus has already taken more than 8.000 lives and infected more than 21.200 people, according to the Center for Disease Control (CDC). The panic raised from this situation rushed the testing of therapies to stop the outbreak and the research on the Ebola virus has seen a rebirth. Some research groups that have been working in this field for a long time can now openly ask for help. One of these groups is the one lead by Dr. Erica Ollman Shaphire at The Scripps Research Institute, California. In 2013 they published in Cell an analysis of the different conformations of Ebola VP40 (Viral Protein 40) aka the shape-shifting “transformer” protein. They reported 3 different conformations of this protein, and how this variety allows it to achieve multiple functions in the viral replication circle. This Ebola virus protein along with the glycoprotein would be used as target for anti viral research. In order to find new anti-virals, their approach is an in-silico scrutiny of thousands of compounds, using viral protein crystal structures in the in silico docking to find leads that may be tested in the lab as inhibitors. IBM is already helping them in this project, generating the World Community Grid to find drugs through the Outsmart Ebola Together project. Here is where you can start helping, as this project involves a huge amount of data and computing time, they need volunteers that can donate their devices spare computing time (android, computer, kindle fire, etc) to generate a faster virtual supercomputer than can accelerate the discover of new potential drugs. This approach has been shown to be successful for other diseases like HIV and malaria, so you are welcome to join the fight against Ebola virus: https://secure.worldcommunitygrid.org/research/oet1/overview.do.
If you do not have any of these devices (I hope you are enjoying the public library free computers), you can still help Dr. Shapire quest to discover new therapies against Ebola. Her group is now “working to support the salary of a computer scientist to help process the data we are generating with the world community grid” as she describes it. To help identify the most promising drug leads for further testing you can donate money on: www.crowdrise.com/cureebola.
Other groups that were mostly working on other viruses, like Flu, also joined the race to discover efficient therapies. For example, last month, the Emerging Microbes and Infections journal of the Nature Publishing Group published the identification of 53 drugs that are potential inhibitors of the Ebola virus. One of the authors of this paper is Dr. Carles Martínez-Romero, from Dr. Adolfo García-Sastre’s lab in the Department of Microbiology at the Icahn School of Medicine at Mount Sinai. In the study, Dr. Martínez-Romero and collaborators described how they narrowed the search from 2.816 FDA approved compounds to 53 potential antiviral drugs. This high-throughput screening was possible thanks to the use of the Ebola viral-like particle (VLP) entry assay. This allows studying Ebola viral entry without using the ”real”, full replicative virus. These 53 compounds blocked the entry of Ebola VLPs into the cell. Understanding how these market-ready compounds can inhibit Ebola entry and its infectious cycle will pave the way for a new generation of treatments against Ebola virus-associated disease.
Dr. Martínez-Romero had an early interest in science; “Since I was a child, I showed great interest in biological sciences and a great desire to question and discover. This led me to pursue my studies in Biotechnology in order to become a successful researcher.”Viruses are very interesting to me because, although they are not strictly living organisms, they are as old as life itself. Even though they are the origin of many illnesses in mammals and other organisms alike, we are tightly interconnected with viruses and they will continue shaping our evolution throughout the years to come.
I also asked him about advice to his fellow researchers, and he answered: “There is a famous quote of Dr. Albert Einstein: “If we knew what we were doing, it wouldn’t be called Research”. As postdocs and researchers in general, we are constantly pursuing new hypotheses. It is a very arduous path with its ups and downs but full of rewards and new challenges ahead.” About the future of the antiviral research, he keeps a positive view: “Several antiviral therapies are being developed to combat the current Ebola outbreak, such as antibody cocktails (Zmapp), antiviral drugs, and specific Ebola vaccines. Together with re-purposing screens like the one we published, a combination of therapeutic drugs can be used to obtain better antiviral strategies against the Ebola virus.”
By Jesica Levingston Mac leod, PhD
Since the start of the outbreak last March, Ebola virus has already taken more than 8.000 lives and infected more than 21.200 people, according to the Center for Disease Control (CDC). The panic raised from this situation rushed the testing of therapies to stop the outbreak and the research on the Ebola virus has seen a rebirth. Some research groups that have been working in this field for a long time can now openly ask for help. One of these groups is the one lead by Dr. Erica Ollman Shaphire at The Scripps Research Institute, California. In 2013 they published in Cell an analysis of the different conformations of Ebola VP40 (Viral Protein 40) aka the shape-shifting “transformer” protein. They reported 3 different conformations of this protein, and how this variety allows it to achieve multiple functions in the viral replication circle. This Ebola virus protein along with the glycoprotein would be used as target for anti viral research. In order to find new anti-virals, their approach is an in-silico scrutiny of thousands of compounds, using viral protein crystal structures in the in silico docking to find leads that may be tested in the lab as inhibitors. IBM is already helping them in this project, generating the World Community Grid to find drugs through the Outsmart Ebola Together project. Here is where you can start helping, as this project involves a huge amount of data and computing time, they need volunteers that can donate their devices spare computing time (android, computer, kindle fire, etc) to generate a faster virtual supercomputer than can accelerate the discover of new potential drugs. This approach has been shown to be successful for other diseases like HIV and malaria, so you are welcome to join the fight against Ebola virus: https://secure.worldcommunitygrid.org/research/oet1/overview.do.
If you do not have any of these devices (I hope you are enjoying the public library free computers), you can still help Dr. Shapire quest to discover new therapies against Ebola. Her group is now “working to support the salary of a computer scientist to help process the data we are generating with the world community grid” as she describes it. To help identify the most promising drug leads for further testing you can donate money on: www.crowdrise.com/cureebola.
Other groups that were mostly working on other viruses, like Flu, also joined the race to discover efficient therapies. For example, last month, the Emerging Microbes and Infections journal of the Nature Publishing Group published the identification of 53 drugs that are potential inhibitors of the Ebola virus. One of the authors of this paper is Dr. Carles Martínez-Romero, from Dr. Adolfo García-Sastre’s lab in the Department of Microbiology at the Icahn School of Medicine at Mount Sinai. In the study, Dr. Martínez-Romero and collaborators described how they narrowed the search from 2.816 FDA approved compounds to 53 potential antiviral drugs. This high-throughput screening was possible thanks to the use of the Ebola viral-like particle (VLP) entry assay. This allows studying Ebola viral entry without using the ”real”, full replicative virus. These 53 compounds blocked the entry of Ebola VLPs into the cell. Understanding how these market-ready compounds can inhibit Ebola entry and its infectious cycle will pave the way for a new generation of treatments against Ebola virus-associated disease.
Dr. Martínez-Romero had an early interest in science; “Since I was a child, I showed great interest in biological sciences and a great desire to question and discover. This led me to pursue my studies in Biotechnology in order to become a successful researcher.”Viruses are very interesting to me because, although they are not strictly living organisms, they are as old as life itself. Even though they are the origin of many illnesses in mammals and other organisms alike, we are tightly interconnected with viruses and they will continue shaping our evolution throughout the years to come.
I also asked him about advice to his fellow researchers, and he answered: “There is a famous quote of Dr. Albert Einstein: “If we knew what we were doing, it wouldn’t be called Research”. As postdocs and researchers in general, we are constantly pursuing new hypotheses. It is a very arduous path with its ups and downs but full of rewards and new challenges ahead.” About the future of the antiviral research, he keeps a positive view: “Several antiviral therapies are being developed to combat the current Ebola outbreak, such as antibody cocktails (Zmapp), antiviral drugs, and specific Ebola vaccines. Together with re-purposing screens like the one we published, a combination of therapeutic drugs can be used to obtain better antiviral strategies against the Ebola virus.”
All the bugs in the metro, tube, subway, from NYC to Asia
Buggy Transportation
All the bugs in the metro, tube, subway, from NYC to Asia
By Jesica Levingston Mac leod, PhD
The New York City (NYC) subway is use for more than 5 million passengers per day. Passengers being humans, pets, bacteria, parasites, viruses and other unknown creatures. Consequently infectious diseases, like influenza can be easily transmitted in this transportation method. Other dangerous circumstances are the black carbon and particle matter concentrations, which In Manhattan are considerably higher than in the urban street level. If you have just ridden the subway, I recommend that you check you washed your hands before continue reading…because, literately, this article is about shit!
Last Month a great research team from Cornell published the studies on microorganisms from 466 subway stations where they found 76 known pathogens (aka “bad” bacteria), and, more interestingly, they found a lot of unknown organisms. This means that almost half of all DNA present on the subway’s surfaces matches no known organism. As they could identified some of the microorganisms, they described that these bacteria were originated in some metropolitan citizen food, pet, workplace… you can actually check which kind of bacteria was found in your favorite/closest subway station… just to be sure what to tell to your doctor next time that you have some infection….
During a year and a half, Dr. Mason, the leader of the group, took samples from materials like the metal handrails in order to collect DNA for the big data genetic metropolitan profile project, aka the Pathomap project. From the 15,152 types of life-forms, almost half of the DNA belonged to bacteria—most of them harmless; However, the scientists said the levels of bacteria they detected pose no public-health problem. The most prevalent bacterial species was Pseudomonas stutzeri, with enrichment in lower Manhattan (aka finance species ;)), followed by strains from Enterobacter and Stenotrophomonas. Notably, all of the most consistently abundant viruses (only 0.03%) were bacteriophages, which were detected concomitant with their bacterial hosts.
Other study done in 2013 in Norway, found that the airborne bacterial levels showed rapid temporal variation (up to 270-fold) on some occasions, both consistent and inconsistent with the diurnal profile. Airborne bacterium-containing particles were distributed between different sizes for particles of >1.1 μm, although ∼50% were between 1.1 and 3.3 μm. Anthropogenic activities (mainly human passengers) were the major sources of airborne bacteria and predominantly contributed 1.1- to 3.3-μm bacterium-containing particles. The peaks are at 8 am and 5 pm, following the rush hours.
Other great discovery was that the human allele frequencies in the subway mirrored US Census data. Within the neighborhoods they found African American and Yoruban alleles correlation for a mostly black area in Brooklyn, Hispanic/Amerindian alleles in the Bronx and they observed that Midtown Manhattan showed an increase in British, Tuscan, and European alleles.
In this globalized world, you won’t be surprised that in the London’s Tube a group of journalist and researchers found more than 3 million bacteria. These data suggested that the average train or bus seat could have more than 70 types of bacteria, plus cold and flu viruses. The North-South Victoria line was the only one that passed the hygiene test.
In a study at the Hong Kong subways system, researchers analyzed aerosol samples in order to find the taxonomic diversity of the “under” microbes. Each bacterial community within a line was dependent on architectural characteristics, nearby outdoor micro biomes, and distance to other lines, and were influenced by temperature and relative humidity.
Altogether these results sound really scary, but I hope that the reader won’t react panicking, but just being aware of the bad pathogens around him/her and carry a hand sanitizer/mask/cleaning aerosol/wipes or just wash your hands with soap! Actually, health officials from the FDA, believe washing hands with soap and water is the best method to get rid of germs.
Posts navigation
All the bugs in the metro, tube, subway, from NYC to Asia
By Jesica Levingston Mac leod, PhD
The New York City (NYC) subway is use for more than 5 million passengers per day. Passengers being humans, pets, bacteria, parasites, viruses and other unknown creatures. Consequently infectious diseases, like influenza can be easily transmitted in this transportation method. Other dangerous circumstances are the black carbon and particle matter concentrations, which In Manhattan are considerably higher than in the urban street level. If you have just ridden the subway, I recommend that you check you washed your hands before continue reading…because, literately, this article is about shit!
Last Month a great research team from Cornell published the studies on microorganisms from 466 subway stations where they found 76 known pathogens (aka “bad” bacteria), and, more interestingly, they found a lot of unknown organisms. This means that almost half of all DNA present on the subway’s surfaces matches no known organism. As they could identified some of the microorganisms, they described that these bacteria were originated in some metropolitan citizen food, pet, workplace… you can actually check which kind of bacteria was found in your favorite/closest subway station… just to be sure what to tell to your doctor next time that you have some infection….
During a year and a half, Dr. Mason, the leader of the group, took samples from materials like the metal handrails in order to collect DNA for the big data genetic metropolitan profile project, aka the Pathomap project. From the 15,152 types of life-forms, almost half of the DNA belonged to bacteria—most of them harmless; However, the scientists said the levels of bacteria they detected pose no public-health problem. The most prevalent bacterial species was Pseudomonas stutzeri, with enrichment in lower Manhattan (aka finance species ;)), followed by strains from Enterobacter and Stenotrophomonas. Notably, all of the most consistently abundant viruses (only 0.03%) were bacteriophages, which were detected concomitant with their bacterial hosts.
Other study done in 2013 in Norway, found that the airborne bacterial levels showed rapid temporal variation (up to 270-fold) on some occasions, both consistent and inconsistent with the diurnal profile. Airborne bacterium-containing particles were distributed between different sizes for particles of >1.1 μm, although ∼50% were between 1.1 and 3.3 μm. Anthropogenic activities (mainly human passengers) were the major sources of airborne bacteria and predominantly contributed 1.1- to 3.3-μm bacterium-containing particles. The peaks are at 8 am and 5 pm, following the rush hours.
Other great discovery was that the human allele frequencies in the subway mirrored US Census data. Within the neighborhoods they found African American and Yoruban alleles correlation for a mostly black area in Brooklyn, Hispanic/Amerindian alleles in the Bronx and they observed that Midtown Manhattan showed an increase in British, Tuscan, and European alleles.
In this globalized world, you won’t be surprised that in the London’s Tube a group of journalist and researchers found more than 3 million bacteria. These data suggested that the average train or bus seat could have more than 70 types of bacteria, plus cold and flu viruses. The North-South Victoria line was the only one that passed the hygiene test.
In a study at the Hong Kong subways system, researchers analyzed aerosol samples in order to find the taxonomic diversity of the “under” microbes. Each bacterial community within a line was dependent on architectural characteristics, nearby outdoor micro biomes, and distance to other lines, and were influenced by temperature and relative humidity.
Altogether these results sound really scary, but I hope that the reader won’t react panicking, but just being aware of the bad pathogens around him/her and carry a hand sanitizer/mask/cleaning aerosol/wipes or just wash your hands with soap! Actually, health officials from the FDA, believe washing hands with soap and water is the best method to get rid of germs.
Posts navigation
Cancer DNA: The New Frontier for Preventing and Curing Cancer
Cancer DNA: The New Frontier for Preventing and Curing Cancer
By Jesica Levingston Mac Leod, PhD
DNA Biomarkers are the hot topic in oncology right now, and the more precise, easy and effective they may be to detect cancer, the better. This cutting edge technique has its origins in the discovery that fetuses shed fragments of DNA into the bloodstreams of the mothers, so do normal and cancer cells. The strategy to search for the most accurate “bar code” for each type of cancer is been approach from a bunch of oncologists around the world.
Researchers from the National Cancer institute, MD, published this month in the Lancet, a correlative biomarker study for lymphoma. In the study publish by Roschewski and col., they detected circulating tumor DNA encoding the clonal immunoglobulin gene sequence (VDJ) in the serum of patients with diffuse large-B-cell lymphoma. The VDJ immunoglobulin genes contain unique sequences that are markers of clonality. Malignant cell VDJ gene sequences could be detected in the serum of patients with diffuse large B-cell lymphoma and used to predict clinical disease recurrence after treatment. For this, they used next-generation DNA sequencing to analyze cell-free circulating tumor DNA in patients assigned to one of three different treatment protocols during a period of 20 years. They concluded that “Surveillance circulating tumor DNA identifies patients at risk of recurrence before clinical evidence of disease in most patients and results in a reduced disease burden at relapse. Interim circulating tumor DNA is a promising biomarker to identify patients at high risk of treatment failure.”
Earlier this year, Hyman and col., reported the analysis of a biomarker (the mutant BRAF(V600E)) in 2 systemic histiocytic disorders characterized by accumulation and infiltration of histiocytes in multiple tissues of the body, leading to organ compromise. These researchers from Memorial Sloan Kettering Cancer Center, New York, showed that in plasma and urinary samples cell free DNA provides a reliable method to detect the mutation that is a biomarker for these disorders, and it can monitor response to therapy in these disorders.
In Australia, the group of doctors Tie, Cosgrove and col., identified and validated 3 protein-based biomarkers in independent cohorts of colorectal cancer (n = 145 and n = 197), which could be translated to a reliable, non-invasive blood-based screening test. The biomarker “winners” were selected by Elisa kits, and they are the following proteins: Insulin like growth factor binding protein 2 (IGFBP2), Dickkopf-3 (DKK3), and Pyruvate kinase M2(PKM2). (3) Anyways, this article is bout DNA markers: So, in a follow up study Tie and col. detected circulating tumor DNA in a high proportion of treatment naïve metastatic colorectal cancer patients. Moreover, they described that early changes in circulating tumor DNA during first-line chemotherapy predict the later radiologic response. On other notes, they also reported that the intake of aspirin is not associated with improvements in survival in colon cancer patients, yeah, bad news for the daily aspirin takers.
Studying the blood samples of healthy elders (“wellderlies”, adults age 80 plus), the team lead by doctor Eric Topol, at the SCRIP center, is trying to find the immune response that attacked and effectively destroyed cancer cells. There is a high probability that these healthy elders had had abnormal cell/cells in their bodies at some point of their lives, which they attacked and destroyed, generating immune memory and powerful anti-cancer antibodies. In fact, a member of the team, Doctor Brunie Felding, had discovered that one of the proteins recognized by “wellderly” antibodies was Apolipoprotein E, suggesting that antibodies against this protein may help develop a targeted therapy against highly-expressing ApolipoproteinE cancers.
These new discoveries, plus the recently FDA approval of three new immuno-oncology therapy drugs, called PD-1 inhibitors, are bright examples of the importance of cancer research funding and support from the public to the government officers.
One of the most influential bioinformaticians/molecular biologists, Dr. George Church, genetics professor at Harvard, thinks that “the DNA is the ultimate computer code and we are all computer programmers”. Therefore, the study of the DNA fragments can help to solve multiple problems… it is working for cancer therapy, and it could be useful to treat even the most common disease: aging.
By Jesica Levingston Mac Leod, PhD
DNA Biomarkers are the hot topic in oncology right now, and the more precise, easy and effective they may be to detect cancer, the better. This cutting edge technique has its origins in the discovery that fetuses shed fragments of DNA into the bloodstreams of the mothers, so do normal and cancer cells. The strategy to search for the most accurate “bar code” for each type of cancer is been approach from a bunch of oncologists around the world.
Researchers from the National Cancer institute, MD, published this month in the Lancet, a correlative biomarker study for lymphoma. In the study publish by Roschewski and col., they detected circulating tumor DNA encoding the clonal immunoglobulin gene sequence (VDJ) in the serum of patients with diffuse large-B-cell lymphoma. The VDJ immunoglobulin genes contain unique sequences that are markers of clonality. Malignant cell VDJ gene sequences could be detected in the serum of patients with diffuse large B-cell lymphoma and used to predict clinical disease recurrence after treatment. For this, they used next-generation DNA sequencing to analyze cell-free circulating tumor DNA in patients assigned to one of three different treatment protocols during a period of 20 years. They concluded that “Surveillance circulating tumor DNA identifies patients at risk of recurrence before clinical evidence of disease in most patients and results in a reduced disease burden at relapse. Interim circulating tumor DNA is a promising biomarker to identify patients at high risk of treatment failure.”
Earlier this year, Hyman and col., reported the analysis of a biomarker (the mutant BRAF(V600E)) in 2 systemic histiocytic disorders characterized by accumulation and infiltration of histiocytes in multiple tissues of the body, leading to organ compromise. These researchers from Memorial Sloan Kettering Cancer Center, New York, showed that in plasma and urinary samples cell free DNA provides a reliable method to detect the mutation that is a biomarker for these disorders, and it can monitor response to therapy in these disorders.
In Australia, the group of doctors Tie, Cosgrove and col., identified and validated 3 protein-based biomarkers in independent cohorts of colorectal cancer (n = 145 and n = 197), which could be translated to a reliable, non-invasive blood-based screening test. The biomarker “winners” were selected by Elisa kits, and they are the following proteins: Insulin like growth factor binding protein 2 (IGFBP2), Dickkopf-3 (DKK3), and Pyruvate kinase M2(PKM2). (3) Anyways, this article is bout DNA markers: So, in a follow up study Tie and col. detected circulating tumor DNA in a high proportion of treatment naïve metastatic colorectal cancer patients. Moreover, they described that early changes in circulating tumor DNA during first-line chemotherapy predict the later radiologic response. On other notes, they also reported that the intake of aspirin is not associated with improvements in survival in colon cancer patients, yeah, bad news for the daily aspirin takers.
Studying the blood samples of healthy elders (“wellderlies”, adults age 80 plus), the team lead by doctor Eric Topol, at the SCRIP center, is trying to find the immune response that attacked and effectively destroyed cancer cells. There is a high probability that these healthy elders had had abnormal cell/cells in their bodies at some point of their lives, which they attacked and destroyed, generating immune memory and powerful anti-cancer antibodies. In fact, a member of the team, Doctor Brunie Felding, had discovered that one of the proteins recognized by “wellderly” antibodies was Apolipoprotein E, suggesting that antibodies against this protein may help develop a targeted therapy against highly-expressing ApolipoproteinE cancers.
These new discoveries, plus the recently FDA approval of three new immuno-oncology therapy drugs, called PD-1 inhibitors, are bright examples of the importance of cancer research funding and support from the public to the government officers.
One of the most influential bioinformaticians/molecular biologists, Dr. George Church, genetics professor at Harvard, thinks that “the DNA is the ultimate computer code and we are all computer programmers”. Therefore, the study of the DNA fragments can help to solve multiple problems… it is working for cancer therapy, and it could be useful to treat even the most common disease: aging.
What's Keeping You Up at Night?
What's Keeping You Up at Night?
If you want to sleep, turn off your electronic device.
The light-emitting devices might be keeping you awake!
By Jesica Levingston Mac Leod, PhD
It is well established by now that staring at your phone, iPad or computer screen before going to sleep may delay your “real sleeping” time. The continued exposure to light excites the receptors in your eyes and therefore your brain, sending the signal that you must stay awake longer. This might not be a problem if you enjoy laying around in bed, tossing from side to side, but most people have to get to work early or have other commitments that haunt them the morning after a bad night of sleep. Insomnia is actually a serious disease; the lack of mindful dreaming can have a negative effect in your daytime life, and can result in poor performance at work. A recent study, published in the SLEEP journal, showed that reducing sleep from 8 hours to 4 hours makes memories less accessible in stressful situations.
Last December, a study in Boston added more evidence to the hypothesis that blue light negatively affects the secretion of melatonin, the hormone that helps regulate sleep and wake cycles. Dr. Chang and collaborators published in PNAS that the use of blue light emitting electronic devices before bedtime reduces a person’s alertness and interferes with their circadian rhythm. In this basic study they compared the effects of reading from a light emitting device verses from a paper book. They found that these e-readers delayed sleep for up to an hour compared to the old-fashioned paper books.
A recent study, published in the Journal of Biological Rhythms also tried to answer the question: can access to artificial light modify our sleeping patterns? Their answer was YES, it does! Sounds pretty legit, right?
Dr. De la Iglesia and collaborators studied two native communities in the north of Argentina: the Tobas and the Qom. These two indigenous communities share similar sociocultural and ethnic heritage, but one difference between them is that only the Tobas have access to electricity. Therefore, the Qom community regulates its lifestyle with natural light, like our ancestors before the almighty Mr. Edison’s invention.
The researchers provided the participants from both communities with motion-tracking wristbands to follow their activity during both summer and winter seasons. They found that in the summer season the Tobas had a tendency to get less daily sleep, about 43 min per day, than those living under natural light conditions. Not surprisingly, this was due to a later daily bedtime and sleep onset in the community with electricity, but a similar sleep offset and rise time in both communities. In the winter, the Qoms slept around 56 min per day more than those with access to electricity, and this was also related to earlier bedtimes and sleep onsets than the Tobas. They concluded: “The access to inexpensive sources of artificial light and the ability to create artificially lit environments must have been key factors in reducing sleep in industrialized human societies.”
But reading the conclusion you learn something else: the Toba community had TVs. This caused them to stay awake even later.
How do you get that pleasant sleep? To listen to lullabies… soft melodies ranging from 60 to 80 beats per minute. Take a warm bath, if body temperature drops before bedtime. Another option is to pay extra attention to your breath: focusing on how air moves through your body can relax you and can reduce stress. My favorite solution is to meditate! At least try – a lot of people accidentally fall asleep while trying to meditate anyways ;).
If you are a device-addicted insomniac, at least decrease the brightness of your screen. Tonight, have a nice encounter with Morpheus and remember that the rest of the human race will appreciate not dealing with a cranky sleepless person tomorrow.
If you want to sleep, turn off your electronic device.
The light-emitting devices might be keeping you awake!
By Jesica Levingston Mac Leod, PhD
It is well established by now that staring at your phone, iPad or computer screen before going to sleep may delay your “real sleeping” time. The continued exposure to light excites the receptors in your eyes and therefore your brain, sending the signal that you must stay awake longer. This might not be a problem if you enjoy laying around in bed, tossing from side to side, but most people have to get to work early or have other commitments that haunt them the morning after a bad night of sleep. Insomnia is actually a serious disease; the lack of mindful dreaming can have a negative effect in your daytime life, and can result in poor performance at work. A recent study, published in the SLEEP journal, showed that reducing sleep from 8 hours to 4 hours makes memories less accessible in stressful situations.
Last December, a study in Boston added more evidence to the hypothesis that blue light negatively affects the secretion of melatonin, the hormone that helps regulate sleep and wake cycles. Dr. Chang and collaborators published in PNAS that the use of blue light emitting electronic devices before bedtime reduces a person’s alertness and interferes with their circadian rhythm. In this basic study they compared the effects of reading from a light emitting device verses from a paper book. They found that these e-readers delayed sleep for up to an hour compared to the old-fashioned paper books.
A recent study, published in the Journal of Biological Rhythms also tried to answer the question: can access to artificial light modify our sleeping patterns? Their answer was YES, it does! Sounds pretty legit, right?
Dr. De la Iglesia and collaborators studied two native communities in the north of Argentina: the Tobas and the Qom. These two indigenous communities share similar sociocultural and ethnic heritage, but one difference between them is that only the Tobas have access to electricity. Therefore, the Qom community regulates its lifestyle with natural light, like our ancestors before the almighty Mr. Edison’s invention.
The researchers provided the participants from both communities with motion-tracking wristbands to follow their activity during both summer and winter seasons. They found that in the summer season the Tobas had a tendency to get less daily sleep, about 43 min per day, than those living under natural light conditions. Not surprisingly, this was due to a later daily bedtime and sleep onset in the community with electricity, but a similar sleep offset and rise time in both communities. In the winter, the Qoms slept around 56 min per day more than those with access to electricity, and this was also related to earlier bedtimes and sleep onsets than the Tobas. They concluded: “The access to inexpensive sources of artificial light and the ability to create artificially lit environments must have been key factors in reducing sleep in industrialized human societies.”
But reading the conclusion you learn something else: the Toba community had TVs. This caused them to stay awake even later.
How do you get that pleasant sleep? To listen to lullabies… soft melodies ranging from 60 to 80 beats per minute. Take a warm bath, if body temperature drops before bedtime. Another option is to pay extra attention to your breath: focusing on how air moves through your body can relax you and can reduce stress. My favorite solution is to meditate! At least try – a lot of people accidentally fall asleep while trying to meditate anyways ;).
If you are a device-addicted insomniac, at least decrease the brightness of your screen. Tonight, have a nice encounter with Morpheus and remember that the rest of the human race will appreciate not dealing with a cranky sleepless person tomorrow.
How Can You Make Money and Help Others with Your Shit?
How Can You Make Money and Help Others with Your Shit?
And other very important poop updates.
By Jesica Levingston Mac leod, PhD
First, you have to be a healthy pooper… Second, you have to live in the Boston area. Your stool can help a person suffering from recurrent C. difficile infections, which is a bacterium that affects 500,000 Americans every year. Where antibiotic treatment has failed to help, a new treatment called “fecal microbiota transplantation” has shown a cure rate of 90%. In this procedure, a fecal microbiota preparation using stool from a healthy donor is transplanted into the colon of the patient. OpenBiome, the startup company based in Boston, helps facilitate this procedure by screening and processing fecal microbiota preparations for use in this treatment. After joining the registration you and your stool will be screened and if you are healthy and a good candidate you will became a donor. If you can succeed with all the tests and you can provide “supplies” quite often then you can exchange money for you poo.
Lately, the study of the human microbiota has been all over the news, specially related with weight control, pregnancy and the infant’s diet. In fact, it’s estimated that the human gut contains 100 trillion bacteria, or 10 times as many bacteria as cells in the human body. Yes, I know what you are thinking: “More of them that my own cells, that cannot be right, right?”
These bacteria, or microbiota, influence your health in many ways, from helping to extract energy from food to building the body’s immune system, to protecting against infection with harmful, disease-causing bacteria.
Researchers are only just beginning to understand how differences in the composition of gut bacteria may influence human health. From what we know so far, here are five ways gut flora can affect your wellness:
Weight Changes
Yes, your gut bacteria affect your eating disorders (or orders if you are lucky). For example the diversity of gut bacteria is higher in lean people compared to obese people. Also, some specific bacteria groups, the Firmicutes and the Bacteroidetes, are linked with obesity. The famous study were they transplanted gut bacteria from obese and lean people to mice, making the host of the first kind of poo gain more weigh that the mice who received the “lean fecal bacteria”, was a shocking confirmation of the importance of the gut bacteria in the body weight regulation. They discovered that the gut bacteria from obese people increase the production of some amino acids, while the material from lean people increases the metabolism of “burning” carbohydrates.
Preterm Labor
Realman and col. found that pregnant women with lower levels of bacteria Lactobacillus in their vagina had an increased risk of preterm labor, compared with women whose vaginal bacterial communities were rich in Lactobacillus. Apparently, the absence of Lactobacillus allows the grown of other species that would have different effects in the pregnancy.
Crying Babies
In a funny study on how diet may affect babies, Pertty and col. showed that giving probiotics to your baby does not change the daily crying time, around 173 minutes, compare to the placebo group (174 min), according to the parental diary. They enrolled 30 infants with colic during the first 6 weeks of life. However, parents reported a decrease of 68% in daily crying in the probiotic and 49% in the placebo group.
Heart Attacks
Gut Bacteria produce compounds can even affect your heart. One of these compounds is the trimethylamine-N-oxide (TMAO), and the presence of it in the blood of the subjects of a recent research study, increased 2.5 times the probability of having a heart attack, stroke or to die over a three-year period compared with people with low levels of TMAO. They have also shown that the metabolism of the gut bacteria changes according of the host’s (your) diet. For example, the consumption of high cholesterol and fatty food can increase the bacterial production of TMAO.
The Immune System
A recent review published in Cell rang the alarm about the negative effect of the “rich countries” diet in the microbiota influencing the immune system. In ideal and normal conditions the immune system-microbiota association allows the induction of protective responses to pathogens and the maintenance of regulatory pathways involved in the maintenance of tolerance to innocuous antigens. In rich countries, overuse of antibiotics, changes in diet, and elimination of constitutive partners, such as nematodes, may have selected for a microbiota that lack the resilience and diversity required to establish balanced immune responses. This phenomenon is proposed to account for some of the dramatic rise in autoimmune and inflammatory disorders in parts of the world where our symbiotic relationship with the microbiota has been the most affected.
Lungs and Asthma
The gut bacteria can affect your lungs: The low levels of 4 gut bacteria strains (Faecalibacterium, Lachnospira, Veillonella, and Rothia) in kids was been recently related to an increase in the risk for developing debilitating asthma. The introduction of these 4 bacteria in mice induced to suffered asthma shown protection as the mice’s lungs did not present inflammation.
The question is: how bacteria IN the guts can affect your other tissues and organs? One study that was just published shows that these bacteria produce chemicals that may help the immune system to battle against other germs. Without this training, the immune system could fail and create inflammation in the lungs. As a follow up from the latest research it may be possible in the near future to predict asthma, and other diseases, as well as cure some illnesses with gut bacteria.
Be ready to give a shit about your shit.
And other very important poop updates.
By Jesica Levingston Mac leod, PhD
First, you have to be a healthy pooper… Second, you have to live in the Boston area. Your stool can help a person suffering from recurrent C. difficile infections, which is a bacterium that affects 500,000 Americans every year. Where antibiotic treatment has failed to help, a new treatment called “fecal microbiota transplantation” has shown a cure rate of 90%. In this procedure, a fecal microbiota preparation using stool from a healthy donor is transplanted into the colon of the patient. OpenBiome, the startup company based in Boston, helps facilitate this procedure by screening and processing fecal microbiota preparations for use in this treatment. After joining the registration you and your stool will be screened and if you are healthy and a good candidate you will became a donor. If you can succeed with all the tests and you can provide “supplies” quite often then you can exchange money for you poo.
Lately, the study of the human microbiota has been all over the news, specially related with weight control, pregnancy and the infant’s diet. In fact, it’s estimated that the human gut contains 100 trillion bacteria, or 10 times as many bacteria as cells in the human body. Yes, I know what you are thinking: “More of them that my own cells, that cannot be right, right?”
These bacteria, or microbiota, influence your health in many ways, from helping to extract energy from food to building the body’s immune system, to protecting against infection with harmful, disease-causing bacteria.
Researchers are only just beginning to understand how differences in the composition of gut bacteria may influence human health. From what we know so far, here are five ways gut flora can affect your wellness:
Weight Changes
Yes, your gut bacteria affect your eating disorders (or orders if you are lucky). For example the diversity of gut bacteria is higher in lean people compared to obese people. Also, some specific bacteria groups, the Firmicutes and the Bacteroidetes, are linked with obesity. The famous study were they transplanted gut bacteria from obese and lean people to mice, making the host of the first kind of poo gain more weigh that the mice who received the “lean fecal bacteria”, was a shocking confirmation of the importance of the gut bacteria in the body weight regulation. They discovered that the gut bacteria from obese people increase the production of some amino acids, while the material from lean people increases the metabolism of “burning” carbohydrates.
Preterm Labor
Realman and col. found that pregnant women with lower levels of bacteria Lactobacillus in their vagina had an increased risk of preterm labor, compared with women whose vaginal bacterial communities were rich in Lactobacillus. Apparently, the absence of Lactobacillus allows the grown of other species that would have different effects in the pregnancy.
Crying Babies
In a funny study on how diet may affect babies, Pertty and col. showed that giving probiotics to your baby does not change the daily crying time, around 173 minutes, compare to the placebo group (174 min), according to the parental diary. They enrolled 30 infants with colic during the first 6 weeks of life. However, parents reported a decrease of 68% in daily crying in the probiotic and 49% in the placebo group.
Heart Attacks
Gut Bacteria produce compounds can even affect your heart. One of these compounds is the trimethylamine-N-oxide (TMAO), and the presence of it in the blood of the subjects of a recent research study, increased 2.5 times the probability of having a heart attack, stroke or to die over a three-year period compared with people with low levels of TMAO. They have also shown that the metabolism of the gut bacteria changes according of the host’s (your) diet. For example, the consumption of high cholesterol and fatty food can increase the bacterial production of TMAO.
The Immune System
A recent review published in Cell rang the alarm about the negative effect of the “rich countries” diet in the microbiota influencing the immune system. In ideal and normal conditions the immune system-microbiota association allows the induction of protective responses to pathogens and the maintenance of regulatory pathways involved in the maintenance of tolerance to innocuous antigens. In rich countries, overuse of antibiotics, changes in diet, and elimination of constitutive partners, such as nematodes, may have selected for a microbiota that lack the resilience and diversity required to establish balanced immune responses. This phenomenon is proposed to account for some of the dramatic rise in autoimmune and inflammatory disorders in parts of the world where our symbiotic relationship with the microbiota has been the most affected.
Lungs and Asthma
The gut bacteria can affect your lungs: The low levels of 4 gut bacteria strains (Faecalibacterium, Lachnospira, Veillonella, and Rothia) in kids was been recently related to an increase in the risk for developing debilitating asthma. The introduction of these 4 bacteria in mice induced to suffered asthma shown protection as the mice’s lungs did not present inflammation.
The question is: how bacteria IN the guts can affect your other tissues and organs? One study that was just published shows that these bacteria produce chemicals that may help the immune system to battle against other germs. Without this training, the immune system could fail and create inflammation in the lungs. As a follow up from the latest research it may be possible in the near future to predict asthma, and other diseases, as well as cure some illnesses with gut bacteria.
Be ready to give a shit about your shit.
Meditation and Science – Crossing Pathways
Meditation and Science – Crossing Pathways
By Jesica Levingston Mac leod, PhD
Good news (as of February 22, 2016): finally science is starting to explain how mindful meditation can be good for your health. Last month, a study published in the Biological Psychiatry journal proved that mindfulness meditation combines the default state network (a network of interacting brain regions known to have activity highly correlated with each other) with a region known to be important in top-down executive control at rest (the left dorsolateral prefrontal cortex), which in turn is associated with improvements in Interleukin -6 levels. Interleukin-5 is a marker of inflammatory disease risk. They recruited 35 jobless adults, who were separated in 2 groups: one group was immersed in a 3-day intensive residential mindfulness meditation and the other group in a relaxation training program. Blood samples and a resting state scan test were taken before and after the program. The key findings indicated that mindfulness meditation training, and not relaxation training, increased posterior cingulate cortex resting state functional connectivity with left dorsolateral prefrontal cortex (a region important in top-down executive control). According to this study “these pre-post training alterations statistically explained 30% of the overall mindfulness meditation training effects on Interleukin-6 at follow-up after 4 months“. In healthy men, elevated levels of Interleukin-6 are related to increased risk of future Myocardial infarction, for example heart attack.
More than 9 years ago I read a study that completely changed my point of view about meditation. I am very lucky to have an open-minded meditation-practicing mother who taught me the basic techniques when I was very young, but as a researcher I did not connect the power of meditation with any “biological” or scientifically proved alteration. Many people meditate to reduce psychological stress and health problems, but my mother taught me to meditate to reach a nirvana-like moment of peace and clarity. We focused on the moment – not searching for fixing any problem – and just enjoyed the experience.
Meditation can be defined in psychological terms as the practice of disciplining one’s attention in an effort to attain a certain state of mind. There are two different types of meditation: spiritual (known for the presence of mantras and thoughts about God and God’s attributes) and secular meditation independent of any religious motivation. In the study that changed my view of this practice, Wacholtz and Pargament (1, 2) studied how these 2 types of meditation helped people deal with pain. They asked the participants to meditate for 20 minutes each day over a period of 2 weeks. One group was told to practice spiritual meditation and a second group would practice secular meditation. A third group of people were asked to not meditate as a control. Then, the researchers performed the simple “please introduce your hand in this cold ice water and try to hold it there as long as you can” method. How long could the participants keep their hand in this very uncomfortable situation? Well, the “spiritual” group had greater decreases in anxiety and more positive mood, spiritual health, and spiritual experiences, plus they tolerated pain almost twice as long as the other two groups. Of course, just meditation gave the participants a better tolerance to the -2C water. In 2008 they published another study where they showed that spiritual meditation was more effective than secular meditation at reducing the severity of migraines in chronic patients.
Recently, a variety of studies are proving that meditation is an effective treatment for stress and pain. For example in Nature Review Neurology, Jensen et al. reviewed a number of publications on this very topic. First of all, they note that meditation is not an invasive therapy, moreover they conclude that the “evidence indicates that mindfulness meditation has both immediate and long-term effects on cortical structures and activity involved in attention, emotional responding and pain”.
On the other hand, a meta analysis published this year by Goyal et al. in JAMA Internal Medicine (they included 47 trials with 3515 participants) found that mindfulness meditation programs had moderate evidence of improved anxiety, depression and pain. They detected low evidence of improved stress/distress and mental health-related quality of life, and low evidence of no effect or insufficient evidence of any effect of meditation programs on positive mood, attention, substance use, eating habits, sleep, and weight. In conclusion, they found no evidence that meditation programs were better than any active treatment, like medicine or workout.
Let’s face it: the happiest guy in the world, Dr. Matthieu Ricard (yes, he has a PhD in molecular biology), meditates often as the basis of his awesomeness, so let’s follow his example… or in scientific language: he has being proving his hypothesis with 100% success, and we can reproduce his experiment at any time in our own lives.
To find a meditation group near you and more information check the free mediation info website.
By Jesica Levingston Mac leod, PhD
Good news (as of February 22, 2016): finally science is starting to explain how mindful meditation can be good for your health. Last month, a study published in the Biological Psychiatry journal proved that mindfulness meditation combines the default state network (a network of interacting brain regions known to have activity highly correlated with each other) with a region known to be important in top-down executive control at rest (the left dorsolateral prefrontal cortex), which in turn is associated with improvements in Interleukin -6 levels. Interleukin-5 is a marker of inflammatory disease risk. They recruited 35 jobless adults, who were separated in 2 groups: one group was immersed in a 3-day intensive residential mindfulness meditation and the other group in a relaxation training program. Blood samples and a resting state scan test were taken before and after the program. The key findings indicated that mindfulness meditation training, and not relaxation training, increased posterior cingulate cortex resting state functional connectivity with left dorsolateral prefrontal cortex (a region important in top-down executive control). According to this study “these pre-post training alterations statistically explained 30% of the overall mindfulness meditation training effects on Interleukin-6 at follow-up after 4 months“. In healthy men, elevated levels of Interleukin-6 are related to increased risk of future Myocardial infarction, for example heart attack.
More than 9 years ago I read a study that completely changed my point of view about meditation. I am very lucky to have an open-minded meditation-practicing mother who taught me the basic techniques when I was very young, but as a researcher I did not connect the power of meditation with any “biological” or scientifically proved alteration. Many people meditate to reduce psychological stress and health problems, but my mother taught me to meditate to reach a nirvana-like moment of peace and clarity. We focused on the moment – not searching for fixing any problem – and just enjoyed the experience.
Meditation can be defined in psychological terms as the practice of disciplining one’s attention in an effort to attain a certain state of mind. There are two different types of meditation: spiritual (known for the presence of mantras and thoughts about God and God’s attributes) and secular meditation independent of any religious motivation. In the study that changed my view of this practice, Wacholtz and Pargament (1, 2) studied how these 2 types of meditation helped people deal with pain. They asked the participants to meditate for 20 minutes each day over a period of 2 weeks. One group was told to practice spiritual meditation and a second group would practice secular meditation. A third group of people were asked to not meditate as a control. Then, the researchers performed the simple “please introduce your hand in this cold ice water and try to hold it there as long as you can” method. How long could the participants keep their hand in this very uncomfortable situation? Well, the “spiritual” group had greater decreases in anxiety and more positive mood, spiritual health, and spiritual experiences, plus they tolerated pain almost twice as long as the other two groups. Of course, just meditation gave the participants a better tolerance to the -2C water. In 2008 they published another study where they showed that spiritual meditation was more effective than secular meditation at reducing the severity of migraines in chronic patients.
Recently, a variety of studies are proving that meditation is an effective treatment for stress and pain. For example in Nature Review Neurology, Jensen et al. reviewed a number of publications on this very topic. First of all, they note that meditation is not an invasive therapy, moreover they conclude that the “evidence indicates that mindfulness meditation has both immediate and long-term effects on cortical structures and activity involved in attention, emotional responding and pain”.
On the other hand, a meta analysis published this year by Goyal et al. in JAMA Internal Medicine (they included 47 trials with 3515 participants) found that mindfulness meditation programs had moderate evidence of improved anxiety, depression and pain. They detected low evidence of improved stress/distress and mental health-related quality of life, and low evidence of no effect or insufficient evidence of any effect of meditation programs on positive mood, attention, substance use, eating habits, sleep, and weight. In conclusion, they found no evidence that meditation programs were better than any active treatment, like medicine or workout.
Let’s face it: the happiest guy in the world, Dr. Matthieu Ricard (yes, he has a PhD in molecular biology), meditates often as the basis of his awesomeness, so let’s follow his example… or in scientific language: he has being proving his hypothesis with 100% success, and we can reproduce his experiment at any time in our own lives.
To find a meditation group near you and more information check the free mediation info website.
Your Teleportation Dream Might Be a Reality Soon
Your Teleportation Dream Might Be a Reality Soon
Scotty, pleaaaase beam me up…
By Jesica Levingston Mac leod, PhD
Jokes aside… well, I can’t stop myself for writing “Scotty, beam me up”, teleportation has already been done with atoms, photons and ions, for example in Universities in China, Germany and Maryland. Are you surprise by all this examples? The process of quantum teleportation of multiple degrees of freedom of a single photon has been done at the University of Science and Technology of China last year. They performed a free-space, ground level link measuring approx. 100 km across the Qinghai Lake in China with high fidelity. The official name of the protocol is “long distance quantum teleportation with polarization qubits” (a quantum bit is the analogue of a “bit” of information). A second group from China has plans to create a quantum space communications system by sending to space a satellite that could facilitate quantum teleportation of photons between earth and space.
Other successful story in teleportation was performed using optical modes. Lee and collaborators generated an EPR state by using two degenerate optical parametric oscillators and a balanced beam splitter. The EPR paradox is a fundamental concept introduced by Einstein, Podolsky and Rosen (their last names initial gave the name to this theory) back in 1935. They claimed that the wave function, as the representation of a particular pure quantum state, does not provide a complete description of the physical reality. Also, quantum teleportation with matter has been performed by other group using atomic ensembles of caesium atoms at room temperature, showing light-to-matter teleportation of a coherent state of an optical mode into a collective atomic spin. More than 13 years ago, Gao and collaborators, performed the amazing quantum teleportation from a propagating photon to a solid-state spin qubit, by exiting a neutral quantum dot onto the electron spin of a charged second quantum dot. So they were the first ones who teleported a photonic frequency qubit. These advances in quantum teleportation are the Holy Grail for the “real” teleportation that we are all crossing fingers to be bring to our everyday world soon…hopefully very soon.
Moreover, these advances in teleportation technology opened the talk to pass to the next frontier: the teleportation of a live organism. The good news on this topic were published in Science at the beginning of this year. Two physicist from China, Tongcang Li and Zhang-qi Yin, propose to put a microorganism with a mass much smaller than the mass of the electromechanical membrane ( for example a bacterium) on top of an electromechanical membrane oscillator integrated with a superconducting circuit to prepare the quantum superposition state of a microorganism and teleport its quantum state. This tiny microorganism will not significantly affect the quality factor of the membrane and can be cooled to the quantum ground state together with the membrane. With a strong magnetic field gradient, the internal states of a microorganism, such as the electron spin of a glycine radical, can be entangled with its center-of-mass motion and be teleported to a remote microorganism. Since internal states of an organism contain information, this proposal provides a scheme for teleporting information between two remote organisms. Basically, what they described was a method to put a microorganism in two places at the same time, and provide a scheme to teleport the quantum state of a microbe (read more about it here). Unfortunately, all this is a just a great theory so far…
Sadly, as an Aprils fool joke, a really good one, the US army reported that they had teleported 9 soldiers from Massachusetts to Germany (here is the funny full article). They remained me that the term “teleportation” has coined by and American author Charles Port in 1931, he was a researcher of anomaly phenomena, phenomena that fall outside of existing understanding.
Recently, German researches from the Institute of Applied Physics at the University of Jena reported the Implementation of quantum and classical discrete fractional Fourier transforms, which represented a huge advance toward teleportation. Back in 2014, they had already generated of a new class of optical beams that are radially self-accelerating and non-diffracting. These beams continuously evolve on spiraling trajectories while maintaining their amplitude and phase distribution in their rotating rest frame. Also check out the fun article in Nature title “photonics: random sudoku light”, were the same authors described how they have imprinted on the laser beam a phase pattern that corresponds to numerical solutions to overlapping sodukus. Translated to “normal” humans it means that they teleported elementary particles (light particles and electrons) in a “spatially delocalized state,” which allows them to be in two separate places at the same time. Oh Germans, such a bunch of funny people… at least in science related fields.
Mr. Elon Musk, founder of Tesla, SpaceX and PayPal, wants to build a high-speed tube service Hyperloop which is capable of travelling around 700 mph. He is targeting to make the trip from Los Angeles to San Francisco as short as 30 min using this “as close as you can get to teleportation” system. Let me leave you with a geeky quote from the book Endure by Carrie Jones: “We teleported,” Issie finishes. “Like in Star Trek or Harry Potter, sort of. No! Like in Dr. Who in that episode with the Sontarans and the brilliant human boy, or really any Dr. Who ever if you think of the Tardis! Holy canola! That is just the coolest thing ever! Wowie, wow, wow!”
Scotty, pleaaaase beam me up…
By Jesica Levingston Mac leod, PhD
Jokes aside… well, I can’t stop myself for writing “Scotty, beam me up”, teleportation has already been done with atoms, photons and ions, for example in Universities in China, Germany and Maryland. Are you surprise by all this examples? The process of quantum teleportation of multiple degrees of freedom of a single photon has been done at the University of Science and Technology of China last year. They performed a free-space, ground level link measuring approx. 100 km across the Qinghai Lake in China with high fidelity. The official name of the protocol is “long distance quantum teleportation with polarization qubits” (a quantum bit is the analogue of a “bit” of information). A second group from China has plans to create a quantum space communications system by sending to space a satellite that could facilitate quantum teleportation of photons between earth and space.
Other successful story in teleportation was performed using optical modes. Lee and collaborators generated an EPR state by using two degenerate optical parametric oscillators and a balanced beam splitter. The EPR paradox is a fundamental concept introduced by Einstein, Podolsky and Rosen (their last names initial gave the name to this theory) back in 1935. They claimed that the wave function, as the representation of a particular pure quantum state, does not provide a complete description of the physical reality. Also, quantum teleportation with matter has been performed by other group using atomic ensembles of caesium atoms at room temperature, showing light-to-matter teleportation of a coherent state of an optical mode into a collective atomic spin. More than 13 years ago, Gao and collaborators, performed the amazing quantum teleportation from a propagating photon to a solid-state spin qubit, by exiting a neutral quantum dot onto the electron spin of a charged second quantum dot. So they were the first ones who teleported a photonic frequency qubit. These advances in quantum teleportation are the Holy Grail for the “real” teleportation that we are all crossing fingers to be bring to our everyday world soon…hopefully very soon.
Moreover, these advances in teleportation technology opened the talk to pass to the next frontier: the teleportation of a live organism. The good news on this topic were published in Science at the beginning of this year. Two physicist from China, Tongcang Li and Zhang-qi Yin, propose to put a microorganism with a mass much smaller than the mass of the electromechanical membrane ( for example a bacterium) on top of an electromechanical membrane oscillator integrated with a superconducting circuit to prepare the quantum superposition state of a microorganism and teleport its quantum state. This tiny microorganism will not significantly affect the quality factor of the membrane and can be cooled to the quantum ground state together with the membrane. With a strong magnetic field gradient, the internal states of a microorganism, such as the electron spin of a glycine radical, can be entangled with its center-of-mass motion and be teleported to a remote microorganism. Since internal states of an organism contain information, this proposal provides a scheme for teleporting information between two remote organisms. Basically, what they described was a method to put a microorganism in two places at the same time, and provide a scheme to teleport the quantum state of a microbe (read more about it here). Unfortunately, all this is a just a great theory so far…
Sadly, as an Aprils fool joke, a really good one, the US army reported that they had teleported 9 soldiers from Massachusetts to Germany (here is the funny full article). They remained me that the term “teleportation” has coined by and American author Charles Port in 1931, he was a researcher of anomaly phenomena, phenomena that fall outside of existing understanding.
Recently, German researches from the Institute of Applied Physics at the University of Jena reported the Implementation of quantum and classical discrete fractional Fourier transforms, which represented a huge advance toward teleportation. Back in 2014, they had already generated of a new class of optical beams that are radially self-accelerating and non-diffracting. These beams continuously evolve on spiraling trajectories while maintaining their amplitude and phase distribution in their rotating rest frame. Also check out the fun article in Nature title “photonics: random sudoku light”, were the same authors described how they have imprinted on the laser beam a phase pattern that corresponds to numerical solutions to overlapping sodukus. Translated to “normal” humans it means that they teleported elementary particles (light particles and electrons) in a “spatially delocalized state,” which allows them to be in two separate places at the same time. Oh Germans, such a bunch of funny people… at least in science related fields.
Mr. Elon Musk, founder of Tesla, SpaceX and PayPal, wants to build a high-speed tube service Hyperloop which is capable of travelling around 700 mph. He is targeting to make the trip from Los Angeles to San Francisco as short as 30 min using this “as close as you can get to teleportation” system. Let me leave you with a geeky quote from the book Endure by Carrie Jones: “We teleported,” Issie finishes. “Like in Star Trek or Harry Potter, sort of. No! Like in Dr. Who in that episode with the Sontarans and the brilliant human boy, or really any Dr. Who ever if you think of the Tardis! Holy canola! That is just the coolest thing ever! Wowie, wow, wow!”
How to Live Long and Prosper – a Vulcan's Dream
How to Live Long and Prosper – a Vulcan's Dream
By Jesica Levingston Mac leod, PhD
A new Harvard study found that we are living longer and better, too. In fact, the life expectancy for a 65 year old in USA grew a lot in the last 20 years: the life expectancy for females is now 81.2 years and for males it’s 76.4 years. The 3 pillars of this improvement are the less smoking, healthier diet and the medical advances. Going straight into the deep science latest developments, two start ups (BioViva and Elysium Health) were in the news recently for their cutting-edge “anti-aging” approaches. The first group to research telomeres gene therapy is Maria Blasco’s group. A study by Bernardes de Jesus et al. demonstrated how telomerese gene therapy in adult and old mice could delay aging and increase longevity, without the collateral effect of increasing the propensity of developing cancer.
In the study, the scientists showed how the treatment of 1- and 2-year old mice with an adeno associated virus expressing mouse telomerase reverse transcriptase (TERT) had beneficial effects on health and fitness, with an increase in median lifespan of 24% and 13%, respectively. Some other benefits included better insulin sensitivity, reduced osteoporosis, improved neuromuscular coordination and improvements in several molecular biomarkers of aging. In cancer cells, the expression of the telomerase is enhanced, giving this protein a bad reputation as having a “tumorigenic activity”. Elizabeth Parrish, the CEO of BioViva, went all the way to Colombia, to receive two gene therapies that her company had developed: one to lengthen the telomeres and the other to increase muscle mass. The results of the treatment were very positive: the telomeres in leukocytes grew from 6.71 kb to 7.33 kb in seven months. As a side note, petite leukocyte telomere length may be associated with several psychiatric disorders (including major depressive disorder) and with poor response to psychiatric medications in bipolar disorder and schizophrenia.
In a nutshell, human telomeres are composed of double-stranded repeat arrays of “TTAGGG” terminating in a single-stranded G-rich overhang. The fidelity of that sequence is maintained by the enzyme telomerase, which uses an intrinsic RNA molecule containing the CAAUCCCAAUC template region and the reverse transcriptase component (TERT), to synthesize telomeric DNA de novo onto the chromosome terminus. The telomeres were named after the greek words télos (end, extremity) and méros (part). Take home message: Telomerase adds DNA to the ends of telomeres and by lengthening telomeres, it extends cellular life-span and/or induces immortalization. The telomerase is not active in normal somatic cells while active only in germ-line, stem and other highly proliferative cells.
Last year, Dr. Fagan and collaborators, published in PLoS One that the transcendental meditation and lifestyle variations stimulate two genes that produce telomerase (hTERT and hTR). Even cheerier news were reported in Nature for thanksgiving: the edible dormouse (super cute, small, long tail mouse – Glis glis) telomere length significantly increases from an age of 6 to an age of 9 years. As they state in the paper “the findings clearly reject the notion that there is a universal and inevitable progressive shortening of telomeres that limits the number of remaining cell cycles and predicts longevity”. These species of mouse skip reproduction in years with low food availability, this “sit tight” strategy in the timing of reproduction might pushed “older” dormouse to reproduce, and this could facilitate telomere attrition, this strategy may have led to the evolution of increased somatic maintenance and telomere elongation with increasing age.
The other company, Elysium, co-founded by MIT professor Lenny Guarente, is focus in the mitochondria and the NAD (nicotinamide adenine dinucleotide). Mitochondria are our energy generators and they get crumbly as we age. Dr. Guarente demonstrated in mice how it may be possible to reverse mitochondrial decay with dietary supplements that increase cellular levels of NAD, like nicotinamide riboside (NR, a precursor to NAD that is found in trace amounts in milk), resveratol (a red wine ingredient) or pterostilbene (present in berries and grapes). Elysium has just realized the results of the clinical trial that was placebo-controlled, randomized, and double-blinded, where they evaluated the safety and efficacy of BASIS (the diateary supplement with nicotinamide riboside (NR) and pterostilbene) in 120 healthy participants ages 60-80 over an eight-week period. Participants received either the recommended dose (250 mg NR and 50 mg pterostilbene) or double the dose. In both cases, the intake of Basis resulted in the increase of NAD+ levels in the blood safely and sustainably, 40% and 90% respectively.
A former Guarante’s postdoc – Dr. Sinclair – has just published in Science the discovery of a NAD binding area in a protein that regulate NAD’s interactions with other proteins related to aging. The Sinclair’s lab reported that the binding of NAD+ to DBC1 (Deleted in Breast Cancer 1 protein) prevents it for inhibiting another protein – PARP1, an important DNA repairing protein. Furthermore, they have shown that as the mice aged, the concentration of NAD+ decreased, and more DBC1 was available to bind to PARP1, culminating in the accumulation of DNA damage. On a brighter note, this process was reversed by restoring higher levels of NAD+. The good news are that NAD+modulation might protect against cancer, radiation and aging.
Although all these advances are great, they won’t make you live longer in the next 10 years, so what can you do to live longer/healthier? Science comes again to answer this question! Harvard studies have shown that living “meaningful lives” helping others, having aims/motivations (and been conscious about the fact that we are taking our own decisions), been grateful, enjoying the present and significant relationships with other humans are key aspects to have a happy live. Obviously, exercising and having natural environments around us, as well as healthy eating are crucial points in a healthy life.
It might be an oversimplification, but 70% of your risk of disease is related to diet: soda and processed food are related with shortening the telomeres. Good news: you can slow down aging with a healthier life style: “Switch to a whole-food, plant-based diet, which has been repeatedly shown not just to help prevent the disease, but arrest and even reverse it” claims Dr. Greger’s, author of the Daily Dozen—a checklist of the foods we should try to consume every day. The super food list includes: Cruciferous vegetables (such as broccoli, Brussels sprouts, cabbage, cauliflower, kale, spring greens, radishes, turnip tops, watercress), Greens (including spring greens, kale, young salad greens, sorrel, spinach, swiss chard), other vegetables (Asparagus, beetroot, peppers, carrots, corn, courgettes, garlic, mushrooms, okra, onions, pumpkin, sugar snap peas, squash, sweet potatoes, tomatoes), beans (Black beans, cannellini beans, black-eyed peas, butter beans, soyabeans, baked beans, chickpeas, edamame, peas, kidney beans, lentils, miso, pinto beans, split peas, tofu, hummus), Berries: (including grapes, raisins, blackberries, cherries, raspberries and strawberries), other fruit (such as apples, apricots, avocados, bananas, cantaloupe melon, clementines, dates, figs, grapefruit, honeydew melon, kiwi, lemons, limes, lychees, mangos, nectarines, oranges, papaya, passion fruit, peaches, pears, pineapple, plums, pomegranates, prunes, tangerines, watermelon), Flax seeds, nuts, spices (like turmeric), whole grains (Buckwheat, rice, quinoa, cereal, pasta, bread) and the almighty: water.
As you can expect, a lot of research is needed to get a magic pill that might boost your life expectancy but you can start investing in your future having a positive attitude, healthy diet, exercising and all the other things that you already know you should be doing to feel better, without forgetting that life is too short, so eat dessert first.
By Jesica Levingston Mac leod, PhD
A new Harvard study found that we are living longer and better, too. In fact, the life expectancy for a 65 year old in USA grew a lot in the last 20 years: the life expectancy for females is now 81.2 years and for males it’s 76.4 years. The 3 pillars of this improvement are the less smoking, healthier diet and the medical advances. Going straight into the deep science latest developments, two start ups (BioViva and Elysium Health) were in the news recently for their cutting-edge “anti-aging” approaches. The first group to research telomeres gene therapy is Maria Blasco’s group. A study by Bernardes de Jesus et al. demonstrated how telomerese gene therapy in adult and old mice could delay aging and increase longevity, without the collateral effect of increasing the propensity of developing cancer.
In the study, the scientists showed how the treatment of 1- and 2-year old mice with an adeno associated virus expressing mouse telomerase reverse transcriptase (TERT) had beneficial effects on health and fitness, with an increase in median lifespan of 24% and 13%, respectively. Some other benefits included better insulin sensitivity, reduced osteoporosis, improved neuromuscular coordination and improvements in several molecular biomarkers of aging. In cancer cells, the expression of the telomerase is enhanced, giving this protein a bad reputation as having a “tumorigenic activity”. Elizabeth Parrish, the CEO of BioViva, went all the way to Colombia, to receive two gene therapies that her company had developed: one to lengthen the telomeres and the other to increase muscle mass. The results of the treatment were very positive: the telomeres in leukocytes grew from 6.71 kb to 7.33 kb in seven months. As a side note, petite leukocyte telomere length may be associated with several psychiatric disorders (including major depressive disorder) and with poor response to psychiatric medications in bipolar disorder and schizophrenia.
In a nutshell, human telomeres are composed of double-stranded repeat arrays of “TTAGGG” terminating in a single-stranded G-rich overhang. The fidelity of that sequence is maintained by the enzyme telomerase, which uses an intrinsic RNA molecule containing the CAAUCCCAAUC template region and the reverse transcriptase component (TERT), to synthesize telomeric DNA de novo onto the chromosome terminus. The telomeres were named after the greek words télos (end, extremity) and méros (part). Take home message: Telomerase adds DNA to the ends of telomeres and by lengthening telomeres, it extends cellular life-span and/or induces immortalization. The telomerase is not active in normal somatic cells while active only in germ-line, stem and other highly proliferative cells.
Last year, Dr. Fagan and collaborators, published in PLoS One that the transcendental meditation and lifestyle variations stimulate two genes that produce telomerase (hTERT and hTR). Even cheerier news were reported in Nature for thanksgiving: the edible dormouse (super cute, small, long tail mouse – Glis glis) telomere length significantly increases from an age of 6 to an age of 9 years. As they state in the paper “the findings clearly reject the notion that there is a universal and inevitable progressive shortening of telomeres that limits the number of remaining cell cycles and predicts longevity”. These species of mouse skip reproduction in years with low food availability, this “sit tight” strategy in the timing of reproduction might pushed “older” dormouse to reproduce, and this could facilitate telomere attrition, this strategy may have led to the evolution of increased somatic maintenance and telomere elongation with increasing age.
The other company, Elysium, co-founded by MIT professor Lenny Guarente, is focus in the mitochondria and the NAD (nicotinamide adenine dinucleotide). Mitochondria are our energy generators and they get crumbly as we age. Dr. Guarente demonstrated in mice how it may be possible to reverse mitochondrial decay with dietary supplements that increase cellular levels of NAD, like nicotinamide riboside (NR, a precursor to NAD that is found in trace amounts in milk), resveratol (a red wine ingredient) or pterostilbene (present in berries and grapes). Elysium has just realized the results of the clinical trial that was placebo-controlled, randomized, and double-blinded, where they evaluated the safety and efficacy of BASIS (the diateary supplement with nicotinamide riboside (NR) and pterostilbene) in 120 healthy participants ages 60-80 over an eight-week period. Participants received either the recommended dose (250 mg NR and 50 mg pterostilbene) or double the dose. In both cases, the intake of Basis resulted in the increase of NAD+ levels in the blood safely and sustainably, 40% and 90% respectively.
A former Guarante’s postdoc – Dr. Sinclair – has just published in Science the discovery of a NAD binding area in a protein that regulate NAD’s interactions with other proteins related to aging. The Sinclair’s lab reported that the binding of NAD+ to DBC1 (Deleted in Breast Cancer 1 protein) prevents it for inhibiting another protein – PARP1, an important DNA repairing protein. Furthermore, they have shown that as the mice aged, the concentration of NAD+ decreased, and more DBC1 was available to bind to PARP1, culminating in the accumulation of DNA damage. On a brighter note, this process was reversed by restoring higher levels of NAD+. The good news are that NAD+modulation might protect against cancer, radiation and aging.
Although all these advances are great, they won’t make you live longer in the next 10 years, so what can you do to live longer/healthier? Science comes again to answer this question! Harvard studies have shown that living “meaningful lives” helping others, having aims/motivations (and been conscious about the fact that we are taking our own decisions), been grateful, enjoying the present and significant relationships with other humans are key aspects to have a happy live. Obviously, exercising and having natural environments around us, as well as healthy eating are crucial points in a healthy life.
It might be an oversimplification, but 70% of your risk of disease is related to diet: soda and processed food are related with shortening the telomeres. Good news: you can slow down aging with a healthier life style: “Switch to a whole-food, plant-based diet, which has been repeatedly shown not just to help prevent the disease, but arrest and even reverse it” claims Dr. Greger’s, author of the Daily Dozen—a checklist of the foods we should try to consume every day. The super food list includes: Cruciferous vegetables (such as broccoli, Brussels sprouts, cabbage, cauliflower, kale, spring greens, radishes, turnip tops, watercress), Greens (including spring greens, kale, young salad greens, sorrel, spinach, swiss chard), other vegetables (Asparagus, beetroot, peppers, carrots, corn, courgettes, garlic, mushrooms, okra, onions, pumpkin, sugar snap peas, squash, sweet potatoes, tomatoes), beans (Black beans, cannellini beans, black-eyed peas, butter beans, soyabeans, baked beans, chickpeas, edamame, peas, kidney beans, lentils, miso, pinto beans, split peas, tofu, hummus), Berries: (including grapes, raisins, blackberries, cherries, raspberries and strawberries), other fruit (such as apples, apricots, avocados, bananas, cantaloupe melon, clementines, dates, figs, grapefruit, honeydew melon, kiwi, lemons, limes, lychees, mangos, nectarines, oranges, papaya, passion fruit, peaches, pears, pineapple, plums, pomegranates, prunes, tangerines, watermelon), Flax seeds, nuts, spices (like turmeric), whole grains (Buckwheat, rice, quinoa, cereal, pasta, bread) and the almighty: water.
As you can expect, a lot of research is needed to get a magic pill that might boost your life expectancy but you can start investing in your future having a positive attitude, healthy diet, exercising and all the other things that you already know you should be doing to feel better, without forgetting that life is too short, so eat dessert first.
Can Chocolate be Good for You? The Dark and Light Side of the Force
Can Chocolate be Good for You? The Dark and Light Side of the Force
By Jesica Levingston Mac leod, PhD
It is this time of the year again: San Valentin (aka Valentine’s Day) – the best excuse to give and more importantly to EAT a lot of chocolate. But, maybe a better gift that receiving chocolate, is to know that eating chocolate might be good for your health.
In the beginning chocolate was “created” as a medicine – a healthy beverage – around 1900 BC by Mesoamerican people. The Aztecs and Mayas gave it the name of “xocolatl”, it means bitter water, as the early preparations of the cacao seeds had an intense bitter taste. Almost one year ago, a longitudinal study, done in the US East Coast, connected eating chocolate with better cognitive function. Yay! Great news, right? The scientists gathered information over a period of 30 years (starting in 1976) from 968 subjects (aged 23-98 years) in the Syracuse-Maine area. The results showed that more frequent chocolate consumption was meaningfully associated with better performance on the global composite score, visual-spatial memory and organization, working memory, scanning and tracking, abstract reasoning, and the mini-mental state examination. Importantly, they pointed out that with the exception of working memory, these relations were not attenuated with statistical control for cardiovascular, lifestyle and dietary factors across the participants.
More good news arrived last summer: an Italian research team announced that flavanol-rich chocolate improves arterial function and working memory performance counteracting the effects of sleep deprivation. The researchers investigated the effect of flavanol-rich chocolate consumption on cognitive skills and cardiovascular parameters after sleep deprivation in 32 healthy participants, who underwent two baseline sessions after one night of undisturbed sleep and two experimental sessions after one night of total sleep deprivation. Two hours before each testing session, participants were assigned to consume high or poor flavanol chocolate bars. During the tests the participants were evaluated by the psychomotor vigilance task and a working memory task, systolic blood pressure (SBP) and diastolic blood pressure (DBP), flow-mediated dilation and pulse-wave velocity. As you might know, sleep deprivation increased SBP/DBP. The result was that SBP/DBP and pulse pressure were lower after flavanol-rich treatment respect to flavanol-poor treatment sleep deprivation impaired flow-mediated dilation, flavanol-rich, but not flavanol-poor chocolate counteracted this alteration. Flavanol-rich chocolate mitigated the pulse-wave velocity increase. Also, flavanol-rich chocolate preserved working memory accuracy in women after sleep deprivation. Flow-mediated dilation correlated with working memory performance accuracy in the sleep condition.
The European Food Safety Authority accepted the following statement for cocoa products containing 200 mg of flavanols: “cocoa flavanols help maintain the elasticity of blood vessels, which contributes to normal blood flow”. This statement means that flavanol-rich chocolate counteracted vascular impairment after sleep deprivation and restored working memory performance. In another study led by Columbia University Medical Center scientists, dietary cocoa flavanols—naturally occurring bioactives found in cocoa—reversed age-related memory decline in healthy older adults. One possibility is that the improvement in cognitive performance could be due to the effects of cocoa flavonoids on blood pressure and peripheral and central blood flow. Following on this other chocolate attribute, it was shown than weekly chocolate intake may be beneficial to arterial stiffness.
But, there are some bad news! A review of 13 scientific articles on this topic, provided evidence that dark chocolate did not reduce blood pressure. However, the reviewers claimed that there was an association with increased flow-mediated vasodilatation (FMD) and moderate for an improvement in blood glucose and lipid metabolism. Specifically, their analysis showed that chocolates containing around 100 mg epicatechin can reliably increase FMD, and that cocoa flavanol doses of around 900 mg or above may decrease blood pressure if consumed over longer periods: “Out of 32 cocoa product samples analyzed, the two food supplements delivered 900 mg of total flavanols and 100 mg epicatechin in doses of 7 g and 20 g and 3 and 8 g, respectively. To achieve these doses with chocolate, you will need to consume 100 to 500 g (for 900 mg flavanols) and 50 to 200 g (for 100 mg epicatechin). Chocolate products marketed for their purported health benefits should therefore declare the amounts of total flavanols and epicatechin”. The method of manufacturing dark chocolate retains epicatechin, whereas milk chocolate does not contain substantial amounts of epicatechin.
The first epidemiological “indication” for beneficial health effects of chocolate were found in Kuna natives in Panama with low prevalence of atherosclerosis, type 2 diabetes, and hypertension. This fact correlated with their daily intake of a homemade cocoa. These traits disappear after migration to urban and changes in diet.
There are many claims about the potential health benefits of chocolate, including anti-oxidative effect by polyphenols, anti-depressant effect by high serotonin levels, inhibition of platelet aggregation and prevention of obesity-dependent insulin resistance. Chocolate contains quercetin, a powerful antioxidant that protects cells against damage from free-radicals. Chocolate also contains theobromine and caffeine, which are central nervous system stimulants, diuretics and smooth muscle relaxants, and valeric acid, which is a stress reducer. However, chocolate also contains sugar and other additives in some chocolate products that might not be so good for your health.
Oh well, maybe the love of chocolate is like any other romantic affair: blind and passionate. Apparently, the beneficial dosage is 10 g of dark chocolate per day (>70% cocoa), so enjoy it as long as the serotonin boost for rewarding yourself with a new treat last.
Happy Valentine’s Day!
By Jesica Levingston Mac leod, PhD
It is this time of the year again: San Valentin (aka Valentine’s Day) – the best excuse to give and more importantly to EAT a lot of chocolate. But, maybe a better gift that receiving chocolate, is to know that eating chocolate might be good for your health.
In the beginning chocolate was “created” as a medicine – a healthy beverage – around 1900 BC by Mesoamerican people. The Aztecs and Mayas gave it the name of “xocolatl”, it means bitter water, as the early preparations of the cacao seeds had an intense bitter taste. Almost one year ago, a longitudinal study, done in the US East Coast, connected eating chocolate with better cognitive function. Yay! Great news, right? The scientists gathered information over a period of 30 years (starting in 1976) from 968 subjects (aged 23-98 years) in the Syracuse-Maine area. The results showed that more frequent chocolate consumption was meaningfully associated with better performance on the global composite score, visual-spatial memory and organization, working memory, scanning and tracking, abstract reasoning, and the mini-mental state examination. Importantly, they pointed out that with the exception of working memory, these relations were not attenuated with statistical control for cardiovascular, lifestyle and dietary factors across the participants.
More good news arrived last summer: an Italian research team announced that flavanol-rich chocolate improves arterial function and working memory performance counteracting the effects of sleep deprivation. The researchers investigated the effect of flavanol-rich chocolate consumption on cognitive skills and cardiovascular parameters after sleep deprivation in 32 healthy participants, who underwent two baseline sessions after one night of undisturbed sleep and two experimental sessions after one night of total sleep deprivation. Two hours before each testing session, participants were assigned to consume high or poor flavanol chocolate bars. During the tests the participants were evaluated by the psychomotor vigilance task and a working memory task, systolic blood pressure (SBP) and diastolic blood pressure (DBP), flow-mediated dilation and pulse-wave velocity. As you might know, sleep deprivation increased SBP/DBP. The result was that SBP/DBP and pulse pressure were lower after flavanol-rich treatment respect to flavanol-poor treatment sleep deprivation impaired flow-mediated dilation, flavanol-rich, but not flavanol-poor chocolate counteracted this alteration. Flavanol-rich chocolate mitigated the pulse-wave velocity increase. Also, flavanol-rich chocolate preserved working memory accuracy in women after sleep deprivation. Flow-mediated dilation correlated with working memory performance accuracy in the sleep condition.
The European Food Safety Authority accepted the following statement for cocoa products containing 200 mg of flavanols: “cocoa flavanols help maintain the elasticity of blood vessels, which contributes to normal blood flow”. This statement means that flavanol-rich chocolate counteracted vascular impairment after sleep deprivation and restored working memory performance. In another study led by Columbia University Medical Center scientists, dietary cocoa flavanols—naturally occurring bioactives found in cocoa—reversed age-related memory decline in healthy older adults. One possibility is that the improvement in cognitive performance could be due to the effects of cocoa flavonoids on blood pressure and peripheral and central blood flow. Following on this other chocolate attribute, it was shown than weekly chocolate intake may be beneficial to arterial stiffness.
But, there are some bad news! A review of 13 scientific articles on this topic, provided evidence that dark chocolate did not reduce blood pressure. However, the reviewers claimed that there was an association with increased flow-mediated vasodilatation (FMD) and moderate for an improvement in blood glucose and lipid metabolism. Specifically, their analysis showed that chocolates containing around 100 mg epicatechin can reliably increase FMD, and that cocoa flavanol doses of around 900 mg or above may decrease blood pressure if consumed over longer periods: “Out of 32 cocoa product samples analyzed, the two food supplements delivered 900 mg of total flavanols and 100 mg epicatechin in doses of 7 g and 20 g and 3 and 8 g, respectively. To achieve these doses with chocolate, you will need to consume 100 to 500 g (for 900 mg flavanols) and 50 to 200 g (for 100 mg epicatechin). Chocolate products marketed for their purported health benefits should therefore declare the amounts of total flavanols and epicatechin”. The method of manufacturing dark chocolate retains epicatechin, whereas milk chocolate does not contain substantial amounts of epicatechin.
The first epidemiological “indication” for beneficial health effects of chocolate were found in Kuna natives in Panama with low prevalence of atherosclerosis, type 2 diabetes, and hypertension. This fact correlated with their daily intake of a homemade cocoa. These traits disappear after migration to urban and changes in diet.
There are many claims about the potential health benefits of chocolate, including anti-oxidative effect by polyphenols, anti-depressant effect by high serotonin levels, inhibition of platelet aggregation and prevention of obesity-dependent insulin resistance. Chocolate contains quercetin, a powerful antioxidant that protects cells against damage from free-radicals. Chocolate also contains theobromine and caffeine, which are central nervous system stimulants, diuretics and smooth muscle relaxants, and valeric acid, which is a stress reducer. However, chocolate also contains sugar and other additives in some chocolate products that might not be so good for your health.
Oh well, maybe the love of chocolate is like any other romantic affair: blind and passionate. Apparently, the beneficial dosage is 10 g of dark chocolate per day (>70% cocoa), so enjoy it as long as the serotonin boost for rewarding yourself with a new treat last.
Happy Valentine’s Day!
Subscribe to:
Posts (Atom)